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ABSTRACT 
Mitral Valve Organ Culture Provides a Novel Experimental 
Paradigm 
by 
Nikhil Gheewala 
Mitral valve diseases and disorders affect tens of thousands of Americans each year, but 
understanding of the disease processes has yet to be fully developed. The behavior and 
characteristics of valve cells and tissue are highly dependent on their surrounding 
environment, including neighboring cells, extracellular matrix composition and 3D 
structure, mechanical forces, and signaling molecules both in the tissue and the 
circulation. In order to study native valve behavior and responses, an ex vivo bioreactor 
system was developed to culture whole mitral valves. The organ culture system simulated 
a physiologically relevant mechanical environment and provided nutrients and gas 
exchange. Valves cultured in this dynamic system retained more native cell and tissue 
characteristics than valves cultured in a static environment. To utilize this novel tool, a 
study was conducted to determine the effects of Angiotensin II on mitral valves, alone 
and in combination with the statin drug, Simvastatin.Angiotensin II was found to alter the 
native valve composition. Simvastatin inhibited some of these alterations, but accentuated 
others and also affected separate valve characteristics. In conclusion, an organ culture 
system for mitral valves has been designed, characterized, validated, and effectively put 
to use in a novel study. 
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Chapter 1 DISSERTATION OVERVIEW 
Mitral valve diseases are responsible for over 40,000 hospitalizations each year in just the 
United States. Treatment options are almost entirely surgical, and the disease progression 
often involves a deterioration of broader cardiovascular health. Most studies of valve 
biology and pathogenesis are conducted in vitro, but these conditions are unnatural and 
strongly influence the behavior of cultured valve cells 
This dissertation is centered on the hypothesis that a physiological mechanical 
environment will help maintain the native characteristics of mitral valves in organ culture 
and serve as a novel experimental paradigm. Such a system offers a new model to study 
heart valve biology by observing the behavior ofthe entire tissue structure. Studying the 
mitral valve at the organ level wi11lead to a better understanding of various valvular 
disorders, especially when accompanied by an altered mechanical environment, such as 
in heart failure. An ex vivo organ culture bioreactor that can mimic the mitral valve's 
mechanical environment was developed; this document describes its purpose, design, 
characterization, and use and discusses the implications of the results. 
The research project was organized into the following three Aims: 
1. Design and mechanically characterize a mitral valve organ culture system capable 
of reproducing the valve's physiologic mechanical environment. 
2. Further develop the organ culture system to integrate a porcine mitral valve in a 
sterile environment with adequate oxygen and nutrients. Evaluate the cultured 
valves to determine the effect of the dynamic mechanical environment. 
1 
3. Employ the organ culture system to study the ex vivo effects of Angiotensin II, 
alone and in combination with Simvastatin, on mitral valve tissue. 
Chapter 2 describes further details about the motivation for this research, basic biology of 
mitral valves, and the concept of mechanotransduction, in which mechanical strains lead 
to biochemical responses. The chapter also summarizes prior literature that has led to the 
current work. The following three chapters will each describe the methods, results, and 
conclusions of the three research Aims. The chapter on Aim I focuses on the mechanical 
aspects of the organ culture system, whereas the chapter on Aim 2 focuses on its 
biological aspects. Aim 3 is distinct from the previous aims in that it does not address the 
development of the organ culture system, but rather utilizes it as a novel experimental 
model. An explanation of the specific study and its background will be reserved for the 
beginning of that chapter. The final chapter discusses the implications of the entire body 
of research. Additionally, appendices have been included to document the design process 
of the organ culture system and its detailed experimental protocol. 
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Chapter 2 BACKGROUND 
The ability of the mammalian heart to provide blood flow throughout the circulatory 
system depends greatly on its four valves. Without the unidirectional flow created by the 
tricuspid, pulmonic, mitral, and aortic valves, the heart would be profoundly inefficient. 
Because of this important role, it is of concern whenever any of the valves becomes 
dysfunctional; in the United States valve disease caused over 21,000 deaths in 2009 and 
contributed to an additional 22,000 deaths (1). 
All but a hundred of these deaths involved valves of the left heart. The left side of the 
heart powers the systemic circulation and is stronger than the right side, creating much 
higher pressure differentials across the left side valves, the aortic valve and the mitral 
valve. Disorders are found more often in these valves and have more deleterious effects. 
Aortic valves were found to be sclerotic or stenotic in 30% of women and men above 65 
years-old; these conditions indicate a 50% greater risk of cardiovascular-related death (2, 
3). Mitral valve prolapse was found in over 2% of middle-aged study subjects (3) and 
results in minor regurgitation. The causes of these disorders are unclear. Current 
treatments for severe mitral valve prolapse include valve repair or a complete valve 
replacement, both involving open-heart surgery. A better understanding of mitral valve 
physiology and pathogenesis can lead to improved options for treatment, early diagnosis, 
and prevention of valve diseases. 
Gross Anatomy 
The mitral valve controls flow between the left atrium and ventricle. The mitral valve's 
complex structure begins at the atrioventricular junction with the roughly 'D'-shaped 
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annulus and extends inwards, forming the leaflets and commissures. The anterior and 
posterior leaflets comprise the majority of the valve, while the comrnissures are relatively 
small and less important to proper valve function. Extending from the ventricular surface 
of the leaflets and commissures are the chordae tendineae, which are anchored by the 
papillary muscles in the ventricular wall. 
The normal physiological behavior of the mitral valve is demonstrated in Figure 2.1. 
During diastole the chordae are relaxed and the leaflets are pressed against the ventricular 
wall as blood flows into the ventricle. As the ventricle contracts during systole, blood is 
pushed towards the atrium. The leaflets fill with blood, billow into the atrium, and press 
against each other to block the passageway into the atrium. The commissures participate 
similarly, but to a smaller extent because of their size. The papillary muscles contract 
synchronously, pulling the chordae taut and preventing the leaflets from prolapsing into 
the atrium. During each cardiac cycle, various regions of the mitral valve experience 
large cyclic strains, both in compression (-0.51 mlm) and in tensionm (0.25 mlm) (4, 5). 
a) 
b) 
Figure 2.1. A) Top view of a mitral valve during 
systole, with the leaflets coapting to prevent 
regurgitant flow. B) Top view of a mitral valve during 
diastole, where the valve leaflets move aside to allow 
blood to fill the ventricle. The chordae tendineae and 
papillary muscles, which contract during systole to 
hold back the valve leaflets and prevent prolapse, are 
seen beyond. 
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Figure 2.2. Layered structure of the mitral 
valve leaflets. The left atrium is at the left 
side of the image and the left ventricle is to 
the right. Yellow saffron staining indicates 
collagen, blue staining indicates 
proteoglycans (PGs), and black indicates 
elastin or cell nuclei. 
A healthy mitral valve exhibits a laminar structure made up of the atrialis, spongiosa, 
fibrosa, and ventricularis layers (6-9). While the transitions between these layers are 
continuous, they are clearly distinguished from one another when tissue sections are 
stained for extracellular matrix (ECM) components (Figure 2.2). These layers are similar 
between the leaflets and vary in thickness, most notably radially from the annulus to the 
end of the leaflets, known as the free edge. On the atrial surface is the atrialis, a layer of 
mostly randomly oriented elastic fibers. The atrialis is thin at the annulus and disappears 
towards the valve free edge. Below the atrialis is the proteoglycan (PG)-rich spongiosa, 
which conversely dominates the valve free edge but shrinks as it approaches the annulus. 
The fibrosa is composed mainly of radially aligned collagen fibers. It is thick at the 
annulus and thins toward the free edge. The final layer is the ventricularis, at the 
ventricular surface. The ventricularis is composed of randomly oriented elastic fibers , 
similar to the atrialis, but is even thinner. 
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Because the layers vary in ECM composition, regions of the valve leaflets exhibit varying 
local ECM compositions depending on the relative contribution of each layer. For 
example, the fibrosa-dominated annulus is represented by a large proportion of collagen, 
some elastin, and little PGs. The chordae tendineae consist of a collagen core surrounded 
by an elastic fiber sheath. The core and sheath extend from and are continuous with the 
fibrosa and ventricularis, respectively. 
Following the idiom that "Form Follows Function" (Davis' Law) in soft tissues, one can 
compare the regional ECM composition with corresponding regional mechanical loading 
characteristics. The valve undergoes the most significant strains during systole, so those 
characteristics will be discussed. As explained above, during this phase the leaflet free 
, 
edges press against each other to form a seal. This pressing together involves a significant 
level of transvalvular compressive stress (4, 5). So, it is not surprising that the free edge 
has a thickened spongiosa, filled with high compressive modulus PGs. Likewise, the 
chordae and the central and annular leaflet regions experience high radial and 
circumferential tensile strains (4, 5), and have a higher concentration of collagen aligned 
in the direction of these strains (7). 
Valvular Cells 
Valvular endothelial cells (VECs) of the mitral valve are part of the endothelial cell 
monolayer that coats the entire inner surface of the cardiovascular system. The valvular 
and vascular endothelial cells are very similar, but are known be morphologically distinct 
(10-13). The VECs appear in a layer of polygonal or elongated cells aligned 
circumferentially on the leaflets and along the length of the chordae tendineae. VECs are 
believed to function both to produce ECM components and hormones and also to regulate 
inflammatory responses, reacting to various agents found in the circulation. 
Valvular interstitial cells (VICs) are found throughout all layers of the valve tissue (14-
18). They are found in up to five sub-populations including both a quiescent, fibroblast-
type morphology and an activated, myofibroblast-type morphology. VICs are responsible 
for the regular ongoing maintainance and remodeling of valvular tissues, as well as 
remodeling in response to changes in environment. They are known to produce collagen 
and PGs, as well as molecules that regulate ECM. Various signals are known to modulate 
these functions, including norepinephrine, paracrine signals from VECs, and mechanical 
stresses (17-25). 
VECs and VICs are often studied separately, however this method does not allow for the 
normal signaling between the two cell types. In a layered hydrogel co-culture under shear 
flow, seeding VECs atop VICs was found to encourage more physiological VIC behavior 
(25). These cells showed a more native phenotype; they had decreased proliferation, 
increased protein synthesis and a reduced loss of GAGs when compared to those cultured 
without a layer of endothelial cells. Attempts to recreate physiological behavior in these 
cells necessitates cell signaling between both VECs and VICs. 
Mechanical Signaling 
Heart valves, like many other tissues in the body, react to their mechanical environment 
not only through deformation, but also through cellular stimulation. The compressive, 
tensile, and shear stresses in the tissue are transferred.to VECs and VICs via the ECM 
and can provoke responses ranging from ECM remodeling to phenotypic modulation. 
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This type of mechanical-to-biochemical signaling is known as mechanotransduction. 
Integrins, transmembrane proteins that connect an individual cell's cytoskeleton to 
adjacent ECM molecules, convey the strains of the surrounding tissue to the cell. Within 
the cell, these integrins bind to anchor proteins, which attach to cytoskeletal actin or 
intermediate filaments and interact with Focal Adhesion Kinase (FAK) molecules (26) to 
transduce the mechanical signal into a biochemical one. 
As explained above, each region of the the mitral valve experiences dynamic mechanical 
conditions throughout the cardiac cycle; these strains are transferred to the cells and have 
been shown to be important in modulating cellular behavior and synthesis of ECM 
components (22, 27, 28). Dynamic strains can also lead to changes in valvular cellular 
function (23, 29, 30). Our research group has previously demonstrated the increased 
synthesis, but reduced retention, of various classes ofPGs (23, 29, 30) in cyclically 
stretched VICs seeded in collagen gels. Cyclic tensile strains have been linked to 
increased collagen production in VICs (23). VICs from porcine aortic valves were seeded 
onto flexible collagen-coated plates and subjected to cyclic strains of 10%, 14%, and 
20% tension. The cells stretched at 14% showed both an increased uptake of 
hydroxyproline, a collagen component, as well as an increase in collagen III mRNA 
expression, though without increase in collagen I expression. Mesenchymal stem cells 
treated identically also showed increases in hydroxyproline uptake and in mRNA 
expression for both collagen types I and III. Other studies corroborate this effect of 
mechanical strains on valve cells (28, 31). 
Valves also experience shear strains associated with blood flow through the valve and 
along valve leaflets and chordae. While the interstitial cells do not directly experience 
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shear flow, the VECs are affected and communicate to them through cell-ECM-cell 
mechanical connections, cytokines, ECM production and growth factor secretion (10), 
resulting in modulation of VIC behavior (25). Like normal strains, physiological levels of 
dynamic shear strain are believed to contribute to normal maintenance of cell functions 
and tissue structure (13). Porcine aortic valve leaflets exposed to various levels of shear 
stress up to 22 dyne/cm2 reversed increases in synthesis of proteins, GAGs, and DNA 
that appeared in static controls, indicating that valve cells cultured without shear stress 
would overproduce these ECM components and over-proliferate (27). Shear strains can 
also lead to types of pathologic remodeling, such as the development of calcific aortic 
stenosis (32). Two groups of human VECs were exposed to shear stresses modeled to 
mimic the stresses experienced on the ventricular and aortic surfaces of the aortic valve. 
The cells exposed to ventricular shear stresses expressed genes linked to the inhibition of 
inflammation. This finding potentially explains the development of calcific plaques on 
the aortic side of aortic valve leaflets and not the ventricular side. It also demonstrates 
that the magnitude of shear stresses is an important factor in mechanotransduction. Shear 
stresses are also observed to cause valvular ECs to align perpendicular to the direction of 
flow, unlike vascular ECs, which align parallel to shear flows (12). These two cell types 
share many similarities, but this observation underscores the need to understand valvular 
cells as distinct cell types. 
Hydrostatic pressure can also cause mechanotransductive effects in heart valves. 
Increases in synthesis of collagen and sulfated GAGs were seen with increases in the 
magnitude of cyclic hydrostatic pressure applied to excised porcine aortic leaflets (33). 
When the frequency of this cyclic pressure was increased above 72 beats per minute 
9 
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(bpm), DNA synthesis increased, suggesting increased cell proliferation. Similar results 
were exhibited by porcine pulmonary valve leaflets: cyclic hydrostatic pressures of 100 
mmHg induced increases in collagen and sulfated GAG content compared to static 
groups and leaflets subjected to only 30 mmHg. However, the cyclic pressure alone did 
not preserve the native valve phenotype. 
-
In addition to mechanotransductive effects, mechanical stimulation influences tissues in 
other ways. Cell-seeded aortic valve tissue engineering scaffolds subjected to dynamic 
flexure demonstrated increased stiffness and increased cellularity through the middle of 
the scaffold (34). The investigators noted that this dynamic motion increased fluid 
perfusion through the scaffold. With increased perfusion, gases and nutrients were 
constantly being distributed throughout the scaffold. The non-vascular valve leaflet likely 
relies on its constant motion to infuse its tissue with fresh nutrients carried in the 
surrounding blood. Additional studies strongly suggest that multiple modes of 
mechanical stimulation are required to maintain the ECM integrity and structure and 
cellular behavior in engineered valve constructs (35, 36). Aortic valve leaflets that were 
cultured ex vivo under static mechanical conditions show reduced cell viability and tissue 
degradation compared to those subjected to organ culture (37). While a lack of dynamic 
stimulation is not the only non-physiologic aspect of this scenario, it surely makes a 
significant contribution to these non-native characteristics. The importance of mechanical 
stimulation plays a large role in the development of the paradigm of organ-level valve 
culture. 
Methods of Studying Valve Biology 
Cell culture is widely used as a powerful tool to study cellular behavior and responses to 
stimuli in a easily controlled and reproducible environment. By isolating cells from the 
ECM and plating them onto a standard substrate, cellular responses to specific stimuli can 
be examined, free from distortion caused by variations in the ECM. Cell culture is 
limited, however, because it does not accurately simulate the cells' natural environment 
and consequently cannot accurately recreate their natural behaviors. This is certainly the 
case for the study of valve cells, which quickly undergo phenotypic modulation away 
from their native state (38). As just discussed in the previous section on heart valve 
biology, a variety of external stimuli influence the behavior and responses of valve cells. 
The two cell types, VICs and VECs, interact with each other through molecular and 
mechanical signals. They also remodel the ECM composition and structure of the valve 
tissue through synthesis and degradation. and conversely vary their behavior with 
changes in this ECM environment. The macroscopic mechanical stresses and strains of 
diastole and systole also affect cell phenotype and proliferation, ECM composition, 
valvular structure and more; reciprocally, the valve's structure and composition can 
enhance or inhibit its intended control of blood flow. The ubiquitous presence of 
circulating molecular signaling agents adds to this mix of complex interactions 
influencing and modulating valve cell behaviors in a manner that cannot be examined 
through cell culture. 
The use of animal models successfully overcomes these drawbacks of cell culture studies. 
Animal models go beyond simulating the mitral valve's natural architecture and 
environment by retaining the valve within its original source. Aside from clinical trials, 
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animals provide the only current paradigm capable of such an holistic analysis and 
include many distal factors which may influence valve behavior more subtly, such as 
circulating cells and hormones. These studies, however, provide very little opportunity to 
control variations between individual animals, especially for larger mammals which have 
not been bred into standardized lines. It is also difficult to precisely control important 
parameters, such as blood pressure, heart rate, blood chemistry, renal influences. Animal 
studies can be laborious because of the supervision a~d conscientious care ofthe animals 
required, as well as the expertise needed to subject an animal to any experimental 
treatment. Heart valve models often involve large mammals, such as pigs and cows, 
which entail larger costs. Studies in smaller mammals are difficult due to anatomic size 
and require smaller equipment. Animal studies are difficult and costly because an entire 
animal must be kept alive in humane conditions. 
In recent years, artificial tissue scaffolds have been seeded with valve cells or similar 
cells to create valve constructs. These constructs have been used both as candidates for a 
tissue engineered heart valve (37) and also as a vehicle to study valve cells (29). These 
constructs combine some of the benefits of cell culture and animal models: a 
reproducible, pre-defined 3D environment that allows a pre-defined set of cells to interact 
with their surrounding architecture. However, they are not yet capable of accurately 
reproducing the anisotropic material properties nor the varied laminar structure of 
valvular tissue (39). 
Organ culture brings many aspects of animal models and introduces them into a much 
more flexible and controllable paradigm. A mitral valve organ culture method provides 
for the entire valve organ to be sustained ex vivo, allowing for experiments that subject 
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the whole valve to a treatment condition instead of just the cells. It also integrates many 
levels of interaction (cells, tissue structure, mechanics, and biochemical influences) found 
in healthy native tissues. It does this in a setting where it is easier to control those 
interactions. The disadvantage of organ culture compared to cell culture would be the 
difficulty of isolating and replicating mechanisms of tissue behavior. Compared to animal 
models, organ culture cannot recreate the entirety of systemic influences, but this is also a 
benefit as these uncontrollable distal influences could serve to confound experimental 
results as much as contribute to them. In order to gain a more complete understanding of 
valvular biology and responses to environmental variation, it is essential to study valves 
in a holistic setting that incorporates cells, ECM, tissue structure, and mechanics. Ex 
vivo organ culture techniques provide this setting along with a higher level of control than 
either standard cell culture or animal models. 
Prior and Current Relevant Work 
Other work has been published describing systems designed to mimic the mechanical 
environment of a variety of cardiovascular organs. They have all created some sort of 
mock circulation, or flow loop, to simulate the mechanical effects of circulatory blood 
flow experienced by vasculature (40, 41), tri-Ieaflet valves (34, 35, 42), and mitral valves. 
They have been applied towards multiple related objectives: hemodynamic flow analyses, 
conditioning natural and engineered valve prostheses, and examination of tissue 
responses to various physiological, pathological, and treatment conditions. 
The system described by Hildebrand was developed to mechanically condition 
engineered aortic and pulmonary valves (42). A electronically controlled pressure 
regulator is used to create a pneumatic physiological pressure waveform in a mock 
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ventricle. The pressure is transferred across a taut membrane to the nutrient medium that 
also acts as the system's flow medium, propelling the medium through the aortic valve 
port and through the flow loop. The flow loop is based on a windkessel model, placing a 
compliance chamber, flow resistor, and raised medium reservoir in line with a circulatory 
loop of tubing that returns the medium to the mock ventricle through a mechanical mitral 
valve. This system uses a algorithm-controlled variable flow resistor to dynamically 
uncouple pressure and flow rates, so that they may be varied independently, allowing 
raised or lowered pressures while maintaining a constant flow rate. This system has 
recently been used to simulate the flow conditions of the right heart for use in 
mechanically conditioning tissue engineered pulmonary valves (35); compared to static 
culture, these valves demonstrated increased DNA content as well as increased collagen 
content and synthesis. 
A similar system has been designed for the organ culture of aortic valves and uses a 
piston pump to create sinusoidal cyclic pressure with amplitudes in the physiologic range 
(37). The author notes that insufficient oxygenation rates could create an adverse 
environment, including altered pH, and lead to cell death. These effects were eliminated 
with the introduction of a novel gas perfusion method. The system has been shown to 
maintain sterile conditions over a period of 96 hours and has been used to culture porcine 
aortic valves for 48 hours. These dynamically cultured valves had comparable levels of 
collagen, sulfated GAGs, and elastin as freshly excised porcine aortic valves. Statically 
cultured valves had significantly less sulfated GAGs and elastin and a trend towards 
reduced collagen, compared to both fresh and dynamically cultured valves. This study 
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strongly demonstrates that, after only two days, mechanical stimulation significantly aids 
in maintaining valve architecture during organ culture. 
A more recently developed system (43) builds on this common flow loop design with the 
goal again of culturing engineered aortic valves. The mock ventricle in this system has 
been shaped to have a smooth contour that greatly reduces flow turbulence and promotes 
velocity uniformity through the aortic valve. The aortic valve holder has also been 
designed with artificial sinuses that are meant to recreate the unique flow profile around 
the valve leaflets. No results confirming sterility of the system have been published. 
Another flow loop system has been developed to analyze the flow characteristics of and 
mechanical forces in mitral valves in various geometrical arrangements. These non-sterile 
studies have described the effects of modifying chordal placement (44), papillary muscle 
placement (45) and annulus shape (45). These flow loops feature positionable force-
sensitive rods holding the chordae in place, able to measure the force needed in the 
papillary muscles, as well as clear windows for video and Doppler imaging. The valve 
annulus is sutured in place and the papillary muscles are bound by dacron fabric, which is 
then sutured to the placement rods. Because these are hemodynamic studies and not 
organ culture the system is filled with a simple saline solution and only a handful of 
cardiac cycles are performed. 
These prior works formed a foundation for the work presented in this dissertation, leaving 
unmet the need for a mitral valve organ culture system. Organ culture of these valves 
requires the provision of both a mechanical and nutrient environment that induces the 
healthy maintenance of mitral valve tissues and cells. The next chapter will discuss the 
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development of an organ culture system for mitral valves, as well as its mechanical 
characterization. 
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Chapter 3 DESIGN AND MECHANICAL EVALUATION OF A PHYSIOLOGICAL 
MITRAL VALVE ORGAN CULTURE SYSTEM 
Introduction 
Chapter 2 detailed the need for continued research into heart valve biology and 
pathogenesis as well as the motivation to pursue an organ culture experimental model. A 
review of existing valve culture systems indicated the need for an organ culture system, 
designed for the mitral valve, that simulates the valve's native hemodynamic 
environment. This chapter documents the first aim in meeting this need: 
Design and mechanically characterize a mitral valve organ culture system capable of 
reproducing the valve's physiologic mechanical environment. 
Thus, the aim of this work was to design a bioreactor system that will provide 
physiological mechanical stimulation for sterile organ culture of a mitral valve, especially 
for longer term studies which would enable detection of slower remodeling changes in 
the valvular microstructure. 
Methods 
Design Criteria 
Design criteria for the mitral valve organ culture system were categorized as functions, 
objectives, or constraints (46). The central function of this design was to maintain an 
organ cultured mitral valve in its native functional state by simulating its in vivo 
nutritional and mechanical environment. Valve cells in vivo are provided with nutrients 
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and mechanical stimulation to remain viable, retain their phenotypic activity, and 
promote stability in ECM composition. Ex vivo, the valve must be immersed in a nutrient 
medium and housed in a system that recreates the normal valve annular size and shape as 
well as the position of the chordae tendineae. This geometry is essential to proper 
coaptation of the valve leaflets, thereby preventing retrograde flow during systole, and to 
unrestricted forward flow during diastole (45, 47,48) (Figure 2.1). 
To develop a system that most effectively performs these desired functions, several 
objectives were defined. The most important objective was to maximize the time period 
that mitral valves remain viable. Also of significance was the objective to minimize the 
changes in tissue structure and composition. Another objective was to maximize the ease 
of operation, such as replacing the culture medium under sterile conditions, which must 
occur at least every two weeks (49). Reducing complexity minimizes possible 
contamination and allows longer culture periods. In order to mimic in vivo conditions, a 
third objective was to create physiological flow rates (-5.0 Llmin) and pressures (peak of 
120 mmHg). A related objective was to maximize flexibility and control of flow rates and 
pressure levels to match the variety of physiologic and pathophysiologic heart rates, 
blood pressures, and cardiac outputs and thus allow a system user to perform 
investigations related to alterations in cardiac mechanics. In order to effectively use the 
system to conduct experiments, additional objectives were to maximize consistency and 
repeatability of culture conditions and maximize the number of valves in culture 
concurrently. 
The design was also dependent on several constraints. This system design was required to 
retain sterility throughout bioreactor assembly, valve dissection, valve insertion into the 
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bioreactor, organ culture system operation and medium replenishment. As a second 
constraint, the system must not leak to prevent contamination or altered mechanics 
through loss of fluid volume. Third, the system size was also constrained to fit within an 
incubator to maintain temperature and gas composition. 
Design Overview 
Based on these design criteria, a mitral valve organ culture system was designed around a 
mock ventricle that uses a pressure-controlled bladder pump to produce pulsatile flow 
(Figure 3.1). Generally, fluid systems can be controlled through flow or through pressure 
differentials; by controlling pressure, this system allows closer control of the pressure 
differentials across the mitral valve, but makes flow rates difficult to adjust or predict. 
The mock ventricle/pumping chamber includes inflow and outflow ports that house the 
tissue mitral valve and mechanical aortic valve. A slack, dome-shaped silicone rubber 
membrane separates a culture medium-filled compartment from an air-filled 
compartment. A computer-controlled pressure regulator increases the air pressure, 
pushing the membrane into the medium-filled side and propelling medium out of the 
mechanical aortic valve, until the 'ventricular' air pressure is decreased to a level lower 
than pressure in the inflow medium, the 'atrial' pressure. At this point, medium flows 
back into the ventricular chamber through the mitral valve, pushing the silicone 
membrane back into the air-filled side of the chamber. 'Aortic' and 'atrial' pressure heads 
are created by elevating a medium reservoir, open to the air through a venting filter. A 
compliance chamber between the ventricular chamber and medium reservoir mimics the 
compliant nature of the circulation. 
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End of diastole 
P ao Pat 
Initial systole 
P < P> P 
at v ao 
Initial diastole 
P > P < P 
at v ao 
Figure 3.1. Pumping schematic. This diagram depicts flow into and out of the ventricular 
chamber during a simulated cardiac cycle. A raised medium reservoir provides an atrial 
filling pressure, Pat' which propels medium into the ventricular chamber through the mitral 
valve. The aortic valve prevents the aortic pressure, P ao, from producing retrograde flow 
into the ventricle. As ventricular pressure, P v, is increased pneumatically, it overcomes P ao 
and medium flows out the aortic valve, while the mitral valve closes. As P v is decreased, the 
aortic valve closes and the mitral valve opens again to allow flow into the ventricular 
chamber. The black arrow indicates movement of the silicone membrane separating culture 
medium from air. Dual wavy arrows indicate flow of medium. The single narrow arrow 
indicates air flow. 
The main determinants for material selection were sterilization and biocompatibility. All 
the organ culture system parts were fabricated with materials able to withstand repeated 
cycles of autoclaving without deformations or other adverse affects; these materials have 
also never been reported to cause toxicity or affect tissue viability. The primary materials 
contacting culture medium include polycarbonate, silicone rubber, polypropylene, 
polyurethane tubing, and polyurethane coated nylon fabric. Stainless steel was used in 
chordal attachments and aluminum was used for an external frame. 
The electronic components of the system were coordinated through a Lab View (National 
Instruments, Austin, TX) virtual instrument (VI). This custom VI used an arbitrary signal 
based on an archetypical ventricular pressure pulse as the basis for the pressure pulse sent 
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to the proportional pressure regulator. The VI allowed real-time adjustment of the signal 
magnitude, displayed instantaneous pressure and flow rate signals, and computed the 
average flow rate. The VI communicated with a National Instruments Data Acquisition 
(DAQ) unit in the main electrical control box that routed the appropriate power and 
communication sources to the computer, flow meter, proportional pressure regulator, and 
pressure sensor. The containment of all electrical wiring within the box with plugs for 
each instrument allowed for extremely quick and easy setup of the electrical system. 
Flow Control and Measurement 
An Airfit Tecno Basic PRE-U proportional pressure regulator (Parker Origa USA, 
Glendale Heights, IL) was used to create pressure pulses for the system. 
Two filter/regulator units were used on a compressed air source at 5.5 bar to produce a 
clean and stable air supply at 1.5 bar. Supported by this pressure source, the proportional 
pressure regulator translated a voltage signal into a pressure waveform ranging 0-200 
mbar (0-150 mmHg). Pressure in the air-side of the ventricular chamber was recorded by 
a pressure transducer (Model EW-68075-40, Cole Parmer, Vernon Hills, IL). Flow into 
the ventricular chamber was measured using an ultrasonic flow meter (Transonic 
Systems, Ithaca, NY) that detects mass flow through tubing without contacting the fluid. 
The specific model, 14 PXL, was chosen for its range of measurable flow rates, 0.025-50 
Llmin, and was factory calibrated for both water at 25° C and culture medium M199 at 
37° C. 
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Flow Loop Components 
The system components were connected with clear PVC or Tygon tubing. Original 
versions of the system used only 5/8" ID Tygon tubing, but most sections of tubing were 
later replaced with 112" ID PVC tubing to reduce the inertial mass of fluid in the system 
and allow greater flow in response to pressure pulses. Although narrower tubing does 
also increase flow resistance, the tubing diameter was still large enough so that these 
contributions to flow resistance were negligible. Approximately 1.5 L of cell culture 
medium acted as the flow medium for the system and provided nutrients; this medium 
was M199 with Earle's salts and L-glutamine (Sigma, St. Louis, MO), supplemented with 
10% bovine growth serum (Hyclone, South Logan, UT) and anti-microbials (200 IU/mL 
penicillin, 200 ug/mL streptomycin, and 500 ng/mL amphotericin B, (Mediatech, 
Manassas, VA)) (50). For a period of seven days, such a large volume of medium 
provides sufficient nutrients for a single valve and remains effective (49), so the culture 
medium was replaced once a week. 
The ventricular chamber was 6.5" long and 4.5" in diameter (Figure 3.2). The silicone 
rubber membrane separating the medium-filled and air-filled compartments was 
positioned at the midpoint of the chamber. This membrane was molded into a dome 
shape with a thickness of .015", which allowed deformation during each pumping cycle 
without inducing significant resistance or tension within the membrane. At the ends of 
the chamber were caps with ports for the pressure transducer and the inflow and outflow 
of air and culture medium. A simple external frame was tightly clamped around the 
chamber with toggle latches to prevent leaking; additionally, many junctions in the flow 
circuit were fitted with silicone o-rings and tightened with hose clamps. A mechanical 
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Figure 3.2. Ventricular Chamber. Pulses of pressurized air act through a dome-shaped 
silicone membrane diaphragm to pump culture medium through a mechanical aortic valve. 
The mitral valve allows medium to flow back into the ventricular chamber. Thus, the valve 
cells receive mechanical stimulation from both the hydrostatic pressure pulses and the 
shear flow across the valve surfaces. 
aortic valve (Carbomedics, Austin, TX) was housed in the outflow port of the ventricular 
chamber. The valve was held in place by a snugly fi tting ring that slides into the outflow 
port around the valve (Figure 3.3). The cultured mitral valve was held similarly in the 
inflow port of the ventricular chamber. 
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Figure 3.3. Outflow port with mechanical aortic valve. A polycarbonate ring fits snugly into 
the outflow port, holding the valve in place. 
A primary function of this design was to hold the cultured mitral valve in a physiologic 
position. In the hemodynamic flow loop previously described (44, 45, 48), the mitral 
valve annulus was sewn to a swatch of Dacron and the papillary muscles were tied to a 
pair of metal posts, which was appropriate for the non-sterile mechanical studies 
performed. Our design adapted these concepts for an organ culture system that was 
intended to operate continuously for weeks instead of hours. The mitral valve was 
obtained from a pig heart obtained from a local abattoir within three hours of death. The 
valve was dissected out of the heart inside a sterile biological safety cabinet with steam 
sterilized tools and gently washed in a 'rinsing' M199 culture medium, as described 
above, fortified with increased anti-microbials (1000 IU/mL penicillin, 1000 ug/mL 
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Figure 3.4. Mitral Valve Attachment. A) Excised Porcine valve sutured to a nylon-coated 
polyurethane swatch. B) Trimmed papillary muscles bound by steel coils. C) Valve annulus 
clamped into place and papillary muscles anchored by straight steel wires. 
streptomycin, and 2500 ng/mL amphotericin B). Before dissection, the valve annulus was 
sized using an annuloplasty sizing set (Duran Ancore, Medtronic, Minneapolis, MN). The 
valve annulus was sewn, using non-biodegradable 3-0 Ethilon sutures (Ethicon, 
Somerville, NJ), to an appropriately sized orifice on a circular swatch of sterilized 
polyurethane-coated nylon fabric (McMaster-Carr, Robbinsville, NJ) (Figure 3.4). Care 
was taken during this process to ensure the valve annulus attained an anatomically proper 
"D" shape. The fabric swatch was then clamped within the inflow port. The chordae 
tendineae were also held in place relative to the inflow port to prevent valve prolapse. 
During dissection, the tips of the papillary muscles were detached from the left 
ventricular wall, retaining the connection with the chordae. The papillary tips held the 
chordae in place and were held in place by helical stainless steel wires wound around the 
papillary tips and interwoven between the chordae tendineae. These helices were in tum 
attached to the interior of the inflow port with additional stainless steel wires. 
The remaining system components were the compliance chamber and atrial reservoir, 
both fabricated from polycarbonate bottles (Nalgene, Rochester, NY) modified with 
tubing ports. The compliance chamber had ports for medium inflow and outflow and 
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contained approximately 400 mL oftrapped air during operation. The atrial reservoir had 
ports for medium inflow and outflow as well as an air vent port, which connected to a 
sterile 0.2 /lm venting filter to allow gas exchange and to provide venting to an 
atmospheric reference pressure. 
Results 
Mechanical Evaluation 
Several mechanical evaluations were performed to determine whether the organ culture 
system could produce pressure and flow response waveforms mimicking a range of 
physiological conditions. The first of these evaluations was conducted at room 
temperature (25 0 C) with water as the flow medium. The atrial reservoir and compliance 
chamber were raised 15 inches above the ventricular chamber and the system positioned 
exactly as it would be in an incubator; a mechanical heart valve was placed in the mitral 
position. Sinusoidal pressure control signals with a peak of 70 mmHg were used to 
determine the frequency response capabilities of the system (Figure 3.5 A&B). The 
measured pressure tracked the control signal within 10 mmHg at 1 Hz, and remained 
fairly accurate at a frequency of 3 Hz, reaching within 15 mmHg of the peak control 
signal. These indicators of the temporal response to a pressure control signal indicated 
that the system is capable of recreating a physiologic pressure pulse. Next, to mimic a 
systolic pressure pulse, the signal was modified to create 60 and 75 bpm 'physiological' 
signals with pressure peaks ranging 75-150 mmHg (Figure 3.5 C&D). The pressure 
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Figure 3.5. Flow Waveforms. Sinusoidal pressure control signals at a) 1 Hz and b) 3 Hz with 
peaks of 70 mmHg and a mechanical outflow valve. Also, physiologic pressure control 
signals at c) 60 and d) 75 bpm with peaks of 120 mmHg and a mechanical outflow valve. 
Similar waveforms were recorded for control signals with peaks ranging from 75-150 
mmHg. 
response tracked the control signal closely in these evaluations, over the full range of 
peak pressures. In each evaluation the measured pressure followed the control signal to 
its peak, within 5-10 mmHg, after a short lag of approximately 0.05 s. At the highest 
pressures, the atrial filling pressure was inadequate to fully replenish fluid in the 
ventricular chamber and the excess fluid breached the atrial reservoir air vent after a few 
minutes. The maximum peak pressure that could be sustained in the system without such 
a breach was 145 mmHg. These breaches were later prevented by modifying the silicone 
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diaphragm to have a smaller range of displacement. The range of pressures that can be 
achieved by the current system is 0 to 150 mmHg, the approximate 
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Figure 3.6. Average flow rate vs. control signal peak pressure in organ culture system with 
mechanical valves in mitral and aortic positions. 
range of the proportional pressure regulator, and allows for the simulation of a range of 
heart pressures from hypotension to hypertension. This range also would allow the 
possibility of using this system to perform mechanical conditioning of engineered tissue 
constructs by applying gradually increasing pressures. Increases in peak pressure resulted 
in linear increases in average flow rate, while pulse frequency had little effect on flow 
rate (Figure 3.6). The maximum average flow rate recorded in the system is nearly 3 
Llmin, which is lower than a typical porcine cardiac output of 5 Llmin (51). 
Similar system response characteristics were found when the system was evaluated with a 
porcine mitral valve in place. The system was filled with culture medium and placed in 
an incubator at 37° C. The flow response was recorded within 3 hours of assembling the 
system. The response included a spike of retrograde (negative) flow during systole as the 
28 
mitral valve leaflets were pushed up and then pressed together to close the orifice (Figure 
3.7). As diastole began, there was a surge of flow through the valve resulting from the 
pressure built up in the compliance chamber, decreasing until the next systolic period. At 
the highest peak pressure of 150 mmHg, the average flow rate reached 2.6 Llmin. This 
evaluation demonstrated the ability of the organ culture system to house a properly 
functioning mitral valve and mimic its physiological flow environment. Although the 
data shown in Figure 3.7 was performed using a single typical specimen, we have 
observed throughout the system's development and evaluation that variations in valve 
size and geometry as well as inherent variation in the attachment procedure produce 
minor variations in flow response. 
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In repeated trials with porcine mitral valves (during the sterility testing described below), 
prolonged retrograde flow was occasionally observed during systole when high pressures 
caused leaks to form along the valve annulus, and would increase in magnitude with time. 
Such leaks introduced non-physiological flow behavior and were reduced by reinforcing 
annular attachments with additional sutures. 
Sterility 
Sterility of this system was demonstrated through several progressively more complicated 
trials. First, the system was set up under zero-flow conditions with a mechanical valve in 
the mitral position and tested for the duration of a week. In this evaluation, each 
component was steam sterilized and then assembled and filled with M199, without 
antimicrobial additives, in a biological safety cabinet. After one week, multiple medium 
samples were collected from distant parts of the system. No sign of contamination was 
seen in the medium under microscope and after one day of culture of medium samples 
swabbed on agar plates, even when contamination was visible on positive control agar 
plates. In subsequent testing of the organ culture system, porcine mitral valves were 
subjected to physiological pulsatile flow with standard culture medium, as described 
previously. At this time, eleven valves have been tested in the system for a range of 3 
days to 3 weeks. Every seven days, the system was removed from the incubator and 
placed in a biological safety cabinet where the culture medium was completely drained 
and refilled. The drained medium was found to be free of contamination, demonstrating 
no observable discoloration and turbidity. The pH of the drained medium was also 
frequently checked as a readout for oxygenation and accumulation of harmful metabolic 
products; in all cases the medium was found to retain the pH of the original medium. 
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During these culture periods, the system was also observed to have no persistent leaks, 
which aided in preventing contamination. 
Discussion 
Development of an organ culture system provides a new and powerful tool for studying 
mitral valve biology by recreating the approximate mechanical environment experienced 
by mitral valves in vivo. This system builds upon the existing paradigms of cell culture 
and animal models by making possible the ex vivo, controlled study of mitral valve tissue 
and cells experiencing physiologically relevant mechanical, cell-cell, and cell-ECM 
interactions. The novelty of this design lies in the applicability to mitral valves, as well as 
the pending demonstration of the extended culture period. 
Mechanical evaluations have shown this system to successfully create a mechanical 
environment similar to that of the native mitral valve. The most notable discrepancy is 
the difference in average flow rate, although a flow rate of at least 2 Llmin is expected to 
provide sufficient shear stress stimulation in conjunction with physiological hydrostatic 
pressure to maintain native valve characteristics. If desired, modifications to the shape 
and size of flow components and pressure control waveform may provide a more 
physiologic flow rate. For example, molding a silicone diaphragm shaped more like the 
interior of the left ventricle may encourage more physiological flow fields, displacing 
more medium. 
Despite this room for improvement, the system described above demonstrates the 
possibility of long-term culture of intact heart valves in a physiological mechanical 
environment. In addition to culturing mitral valves, this system could be readily modified 
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to culture any of the other 3 cardiac valves or possibly other cardiovascular tissues. These 
mechanical performance characteristics are intended to contribute to the primary goal of 
this design, maintaining valve cellular and microstructural viability; evaluating these 
characteristics will be the focus of Chapter 4. 
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Chapter 4 ORGAN CULTURE OF MITRAL VALVES AS A NOVEL 
EXPERIMENTAL PARADIGM 
Introduction 
The design and mechanical characterization of a dynamic, pulsatile flow loop system for 
the organ culture of a mitral valve was described in Chapter 3, with additional design 
details in Appendix A. This system provides a physiologic pressure profile to produce 
dynamic flow and mimic the native environment of the mitral valve. The current chapter 
focuses on the following aim: 
Further develop the organ culture system to integrate a porcine mitral valve in a sterile 
environment with adequate oxygen and nutrients. Evaluate the cultured valves to 
determine the effect of the dynamic mechanical environment. 
The effectiveness of the dynamic organ culture system can be demonstrated by showing 
that valves cultured in the system better retain native characteristics better when 
compared to valves cultured without mechanical stimulation (static culture). The purpose 
of the work described in this chapter was to compare the structure, composition, and 
material properties of porcine mitral valves dynamically cultured for 3 weeks with 
statically cultured and freshly harvested specimens. 
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Materials & Methods 
Organ Culture System 
The porcine mitral valve was located within the inlet port of the pumping chamber and a 
mechanical aortic valve was located at the outlet port. The entire system was filled with 
approximately 1.4 L M199 culture medium, supplemented with 10% Bovine Growth 
Serum (BGS, Thermo-Hyclone, Logan, UT) and 1 % anti-microbial solution (200 IU/mL 
penicillin, 200 ug/mL streptomycin, and 500 ng/mL amphotericin B; Mediatech, 
Manassas, VA). The pressure waveform was controlled by a Virtual Instrument 
programmed with LabView software (National Instruments, Austin, TX) and 
approximated a left ventricular pressure cycle. 
Harvest, Preparation, and Culture of Valves 
The following procedure was followed to integrate porcine mitral valves into the organ 
culture system. A more detailed set of instructions can be found in Appendix B: Flow 
Loop Operating Manual. Pig hearts were obtained from a local abattoir (Fisher'S Ham and 
Meats, Spring, TX). Within six hours postmortem, the entire mitral valve was harvested 
intact, including the papillary muscles. Porcine mitral valves were assigned to three 
groups: freshly (F) excised mitral valves: nF = 7, statically (S) cultured valves: ns = 7, and 
dynamically (D) cultured valves: nD = 5. Group F valves were harvested in a non-sterile 
environment and immediately prepared for mechanical, histological and biochemical 
analyses. 
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Valves intended for static or dynamic organ culture (Groups S & D) were harvested in a 
biological safety cabinet with sterilized surgical tools to maintain a sterile procedure. 
After harvest, these mitral valves were stored in sterile Phosphate Buffered Saline (PBS) 
augmented with a high dose (10%) anti-microbial solution for two hours, or in two cases 
for 14 hours under refrigeration. This step was intended to reduce any pre-existing 
microbial contamination resulting from the slaughter and pre-harvest handling of the 
heart. During harvest and preparation, handling of the valve surfaces was minimized to 
avoid disrupting the endothelium. 
Groups Sand F were then prepared for integration into the organ culture system. Group S 
(static culture) valves were prepared similarly to Group D (dynamic culture) valves to 
isolate the effects of mechanical stimulation. The valve annuli were sutured to an orifice 
cut into a circular swatch of nylon-coated polyurethane (McMaster-Carr, Santa Fe 
Springs, CA) (Figure 3.4a). Each swatch was paired by visual inspection to best match 
orifice and annulus dimensions. After preparation, group S valves were placed in a cell 
culture flask and submerged in approximately 75 mL M199 culture medium with 10% 
BGS (Figure 4.1). These flasks were maintained in a humidified incubator at 37° C and 
5% CO2 for a duration of 21 days; the culture medium was exchanged every 2-3 days. 
As the preparation of group D valves continued, the papillary muscles were trimmed and 
bound by helical steel wires so that the chordae extended out perpendicular to the helical 
axis (Figure 3.4b). After this preparation, the valves were again stored in a fresh sterile 
PBS/I0% anti-microbial solution for up to two hours. The valves were then fitted into the 
inlet port of the organ culture system and the papillary muscle helices were anchored in 
place with straight steel wires to hold the chordae in an extended position (Figure 3.4c). 
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The entire organ culture system was then assembled from steam sterilized components in 
a biological safety cabinet and filled with Ml99 culture medium. The system was placed 
in the incubator and connected to the electronic control system. 
Figure 4.1. Static culture environment. Group S valves were prepared for dynamic culture 
but instead submerged in a cell culture flask ruled with culture medium. 
For each valve in Group D, the organ culture system was run for 21 days with a 60 bpm 
cycle and peak pressure of 120 rrunHg. The culture medium was exchanged every 7 days. 
Upon draining the system, the pH of the culture medium was measured to detect whether 
insufficient gas exchange or cellular metabolites affected the biochemistry of the culture 
medium. During operation of the organ culture system, pressure within the ventricular 
chamber and flow through the mitral valve were measured and recorded at least three 
times per hour to track the system and valve function. Flow measurements of full 
pumping cycles were selected from five time points during each valve's culture: Days 1, 
4, 7, 14, and 21. The total flow rate was calculated by integrating the instantaneous flow 
rate. Forward flow was calculated from the integral of all positive flow values and 
retrograde flow from the integral of all negative flow values. 
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After 21 days of culture, groups S & D were removed from the culture flasks and organ 
culture system and prepared for analysis. Valves from all three groups were 
photographed and dissected into seven sample sections (Figure 4.2). These sections were 
identified as: radial strip from the anterior leaflet (AR), circumferential strip from the 
anterior leaflet (AC), two anterior strut chordae (Ch), remaining anterior leaflet tissue 
(Ant), radial strip from the posterior leaflet (PR), remaining posterior leaflet tissue 
(Post). The Ant and Post sections were used for biochemical analyses, while the other 
sections were reserved for material testing and were subsequently prepared for 
histological analyses. 
Figure 4.2. Mitral valve sections. After culture, the valves were dissected into seven sections. Five 
were used for materials testing and histology: AC - Anterior Circumferential, AR - Anterior 
Radial, PR - Posterior Radial, Ch (x2) - Chordae Tendineae. Two were used for biochemical 
assays: Ant - Anterior Leaflet, Post - Posterior Leaflet. 
Biochemical Analyses 
Each Ant and Post tissue sample was weighed before and after freeze-drying to determine 
water content. These samples were then rehydrated in ammonium acetate, minced, and 
digested with approximately 10 mg/mL Proteinase-K (Invitrogen, Carlsbad, CA) at 
60°C for 16 hours or until digestion was judged complete by visual inspection, at which 
time the samples were heated to 70°C for 30 minutes to denature the Proteinase-K (52). 
Cellularity was measured with the fluorescent PicoGreen dye (Invitrogen) 
to quantify DNA content (53). Because DNA content is constant among porcine cells, 
this is a direct measurement of relative cellularity. Glycosaminoglycan (GAG) content 
was measured through an uronic acid colorimetric assay (54). Collagen content 
was measured through a colorimetric assay that detected hydroxyproline, an amino acid 
found nearly exclusively in collagen in a proportion of 131 Ilg hydroxyproline per 
1000 Ilg of type I collagen (55). 
Materials Testing 
The remaining sections (AR, AC, PR, and Ch) were subjected to a uniaxial tensile testing 
regimen using an EnduraTEC ELF 3220 (Bose, Eden Prairie, MN). These tests were 
conducted in a water bath filled with PBS maintained at 37° C. Prior to testing, the 
thickness, width, and gauge length of each sample were measured for calculation of stress 
and strain. Load and displacement values were recorded as the valve sections were 
stretched according to a predetermined displacement regimen. The regimen included 
three phases of elongations of increasing magnitude in order to demonstrate a broad 
range of stress-strain responses for each specimen regardless of its length or other 
elongation limits. As shown in Table 4.1, each phase began with a preconditioning 
regimen of several 1 Hz triangle waves, followed immediately by a 0.5 Hz elongation 
segment of the same magnitude, which was used to determine a tensile modulus. Phase 1 
consisted of a simple load-elongation test. During phases II and III, after the pre-
conditioning the elongation was held for a period of 60 seconds to observe viscoelastic 
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stress relaxation behavior. Displacement was then returned to zero and the samples were 
rested for 60 seconds before the next elongation phase. 
Table 4.1. Materials Testing Regimens 
Phase 
I II III 
Elongation magnitude (mm) 2 3 5 
Pre-conditioning cycles 25 6 6 
Stress relaxation duration (s) 0 60 60 
Rest period (s) 60 60 N/A 
A Typical Load-ElongationAnalysis B Typical Stress-Relaxation 
0.20 Segment 
0.1 --Load·Elongation Data 2 .~ ] 
'""' 
- - Linear Regression 
&: 0.10 g 1.5 6- -e 
,,, ~ 1 Vl 0.05 0 t1) ....:I 
.l:l 
CIl 0.5 
0.00 0 
Extensibility I 0 
·0.05 
20 40 60 80 
0.000 0.050 0.100 0.1 50 0.200 Time (s) 
Strain 
Figure 4.3. Material testing data analysis. A) A typical load-elongation curve. A linear 
regression was fit to the linear portion of the curve. The slope of the regression was 
interpreted as the tensile modulus and the x-intercept as the extensibility. B) A typical stress 
relaxation curve. A bi-exponential decay was fit to the entire curve. 
Afterwards, the post-transition modulus, extensibility, and stress relaxation rate constants 
for each tested specimen were calculated from the load-displacement data (Figure 4.3). 
Stress was calculated by dividing the load data by the cross-sectional area of the sample. 
Strain was calculated by dividing the displacement data by the gauge length. The elastic 
tensile modulus was determined for each phase by performing a linear regression on the 
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steepest portion of the stress-strain curve of the 0.5 Hz elongation segment using Excel 
software (Microsoft Corp, Redmond, W A). This "post-transition" modulus (56) often 
varied among phases, depending on the strain experienced. When specimens were not 
elongated to a sufficiently high enough strain, they demonstrated decreased tensile 
moduli. In addition, strains that were too large often caused tissue or grip failure during 
pre-conditioning and also resulted in reduced moduli. Because the three-phase testing 
protocol provided three strain windows, the greatest value of the modulus that was 
calculated from the three phases was selected as the most representative of the post-
transition modulus of each tissue specimen. Extensibility, which demonstrated the tissue 
specimens' capacity to deform without requiring a significant load, was defined as the x-
intercept of the linear regression used to calculate the modulus. The stress relaxation data 
were modeled as a bi-exponential decay, described by the following equation. 
+Ao -k x+A -k x y = yo e fast Ie slow 
The Kfast and Kslow parameters were calculated iteratively using GraphPad Prism 
(GraphPad Software, LaJolla, CA). The parameter Yo was determined as the plateau 
stress, an asymptotic value approximated by the stress at the end of the 60 second 
relaxation period. 
Histological Staining 
After tensile testing, the sections were fixed with formalin overnight, dehydrated using a 
series of graded alcohols, soaked in xylene, and embedded in paraffin blocks according to 
standard procedures for histological processing. Tissue blocks were sliced into 5 /lm 
thick cross-sections and affixed to glass slides. Tissue cross-sections were stained with a 
Movat Pentachrome to visualize ECM and the layered leaflet structure. Samples were 
also stained with Picrosirius Red to observe collagen fiber alignment. As described in 
Table 4.2, immunohistochemical (IHC) staining was also used to localize several markers 
of cell and tissue phenotype. In order to control for the staining intensity of the 
hematoxylin counterstain and any non-specific binding, negative controls for each 
secondary antibody were performed with no primary antibody on every specimen. In 
addition, a set of hematoxylin-only slides were prepared to quantify non-specific binding 
and as a measure of cellularity. 
Prior to analysis of the staining results, most slides were digitally scanned at 7200 dpi 
with a slide scanner (PathScan Enabler IV, Meyer Instruments, Houston, TX) to facilitate 
analysis. The Picrosirius Red slides were instead imaged with a Leica DMIL microscope 
(Buffalo Grove, IL) under polarized light using the lOX objective and photographed 
using a Leica DFC 320 imaging system and ImagePro software (Media Cybernetics, 
Bethesda, MD). Radial sections were imaged at the valve insertion, mid-leaflet, and at the 
free-edge. They were then analyzed semi-quantitatively for staining brightness and the 
uniformity of collagen alignment and sorted into four grades for each characteristic 
(Figure Figure 4.5). Movat-stained sections were analyzed semi-quantitatively for 
delineation of the distinct layered structure, abundance of saffron-stained collagen, and 
abundance of alcian blue-stained GAGs (57). Slide images were randomized and two 
blinded observers assigned a grade of I to 4 for each characteristic. 
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Table 4.2. Immunohistochemistry Markers. Antibody sources: A) Abcam, Cambridge, MA. 
B) Lab Vision, Fremont, CA. C) A gift from Dr Larry Fisher, NIH. D) Associates of Cape 
Cod, East Falmouth, MA. HA is detected using HA binding protein, not an antibody. E) 
Millipore, Billerica, MA. F) Dako, Carpinteria, CA. 
Marker Dilution 
Caspase-3 A 1:50 
CD-31 B 1:50 
Decorinc 1:500 
(LF-122) 
H yaluronan D (HA) 1:250 
Proliferating Cell 1:500 
Nuclear Antigen 
(PCNA)A 
Prolyl-4- 1:200 
Hydroxylase 
(P4H)E 
Smooth Muscle a- 1: 1000 
Actin (SMaA)F 
VersicanD 1:500 
Secondary Antigen 
Antibody Retrieval Relevance 
Rabbit 
Rabbit 
Rabbit 
N/A 
Rabbit 
Mouse 
Mouse 
Mouse 
Citric Acid - Marker for cellular 
Heat Mediated apoptosis 
Citric Acid - Endothelial cell 
Heat Mediated marker 
Chondroi tinase Collagen formation 
ABC and organization 
None Located in areas of 
compressive loads 
Citric Acid - Denotes magnitude of 
Heat Mediated cellular proliferation 
Citric Acid - Enzyme marker of 
Heat Mediated collagen synthesis 
Citric Acid - Valve cell activation, 
Heat Mediated localized in valve 
lesions 
Chondroitinase Located in areas of 
ABC compressive loads, 
disrupted in valve 
disorders 
Figure 4.4. A typical radially oriented 
section of the mitral valve. The Fibrosa, 
Spongiosa, and Free-edge regions are 
indicated. Yellow saffron staining 
indicates collagen, blue staining indicates 
PGs, and black indicates elastin or cell 
nuclei. 
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Figure 4.5. Picrosirius Red Grading. A) From 1 to 4, little to high staining brightness. B) 
From 1 to 4, little to high collagen organization and alignment. 
Slides stained with IHC were analyzed to determine the relative staining intensity of each 
marker, both throughout the tissue cross-section as well as in individual valve layers 
(Figure 4.4) when such layers were apparent in staining. Calculation of average staining 
intensity was automated with a batch macro in ImageJ (NIH, Bethesda, MD) that utilized 
particle analysis to isolate tissue sections from the image background. The resulting value 
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was a measurement of the average staining intensity of each cross-section. Because CD-
31 is a marker for endothelial cells, the intensity of anti-CD-31 immunostaining was not 
analyzed throughout the tissue sections. Instead, endothelial staining in these sections 
was observed under a Leica DMIL microscope using the 5X objective and photographed 
using a Leica DFC 320 imaging system and ImagePro software. 
Statistical Analysis 
Statistical calculations were performed using JMP software (SAS, Cary, NC). Average 
values were calculated and are expressed here as mean ± SE. Each group of data was 
analyzed by a two-way ANOV A, separating specimens by experimental group (F/S/D) as 
well as valve section (Post! Ant or ARI AC/PRlCh). ANOV A was also performed on 
staining intensity measurements isolated from specific valve regions. This data was 
separated by valve section and compared across experimental group and region. When 
results were inconsistent across valve sections, data was also analyzed by one-way 
ANOV A across experimental group. In certain cases, sections were separated into 
radially oriented (ARlPR) and ACICh "section types" that share similarities in typical 
loading and structural characteristics. Separate two-way ANOV As were performed on 
each section type across section and experimental group. When ANOV A suggested 
statistical differences, a Tukey's test was used for post-hoc analysis between groups with 
the level of significance set at 0.05. 
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Results 
Flow Through the Mitral Valve 
After introduction into the organ culture system all mitral valves demonstrated roughly 
physiological flow patterns, clearly indicating proper opening and closing of the valve 
leaflets. These valves consistently showed a gradual, and statistically significant (p < 
0.001) increase of retrograde flow, from an average of 0.4 ± 0.1 L/min to 1.7 ± 0.3 L/min, 
as the culture period progressed (Figure 4.6). Combined with the constant forward flow, 
this resulted in a significant (p < 0.05) drop in the total (net) flow rate from 2.2 ± 0.1 
L/min on Day 1 to 1.0 ± 0.4 L/min on Day 21. The recorded pressure patterns did not 
change significantly during the 21 days of culture (data not shown). 
Gradual Increase of Retrograde Flow 
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Days of Culture 
.... TotalFlow -*-Forward Flow -.... Retrograde Flow 
Figure 4.6. Average flow characteristics through the mitral valve. This chart represents the 
culture periods of five separate valves. 
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Macroscale Anatomy 
Valves from groups F, S, and D typically exhibited slightly different 
appearances. Compared to the control valves, the leaflets in the static group were 
observed to be enlarged. The leaflets in the dynamic group were not visibly enlarged, but 
did appear less glossy than those in the other groups. A two-way ANOVA of thickness 
measurements indicated a significant thickening of valve leaflets and chordae under both 
dynamic (p= 0.0262) and static (p = 0.0003) culture conditions compared to fresh leaflets 
and chordae (Table 4.3). 
Table 4.3. Thickness (mm) of Valve Sections in Different Groups. 
Tissue Section Fresh Static Dynamic 
AC 1.00 ± 0.09 1.30 ± 0.07 1.30 ± 0.11 
AR 1.19±0.17 1.67 ± 0.12 1.48 ± 0.25 
PR 1.10 ± 0.14 1.51 ± 0.15 1.38 ± 0.20 
Ch 1.17 ± 0.08 1.46 ± 0.11 1.35 ± 0.07 
Biochemical Assays 
Biochemical assay measurements for all four analytes were consistent between anterior 
and posterior leaflet sections, so these sections were grouped and analyzed together. The 
valves cultured under static conditions contained significantly more water by weight 
(90.6 ± 0.3%) than fresh valves (88.9 ± 0.4%, P = 0.0055) and dynamically cultured 
valves (88.4 ± 0.7%, P = 0.0257) (Figure 4.7). The statically cultured group was also 
remarkably different with regards to cellularity (Figure 4.8), with only a small fraction of 
DNA (1.1 ± 0.2 ~glmg dry wt) compared to fresh valves (10.3 ± 0.7 ~g/mg, p < 0.0001) 
and dynamically cultured valves (6.9 ± 1.1 ~glmg, p < 0.0001). There was also a smaller, 
46 
Tissue Hydration 
by Weight 
100% 
95% 
90% 
85% 
80% 
75% 
Fresh Static Dynamic 
- Ant OPost 
Figure 4.7. Tissue hydration by weight. 
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but still significant, difference between the cellularity of fresh and dynamically cultured 
mitral valves (p = 0.0045). 
The analyses ofECM composition gave mixed results. There was no statistically 
significant difference in hydroxyproline and thus collagen concentration between groups 
(Figure 4.9), although there was a trend of slightly greater collagen concentration in the 
dynamic and static culture groups when compared to fresh valve leaflets (p = 0.1104). 
Compared with fresh leaflets, there was a statistically insignificant loss of 
glycosaminoglycans during static culture, and also during dynamic culture (Figure 4.10); 
the GAG concentrations were similar between the two culture groups. 
Materials Testing 
Mechanical testing of the leaflets and chordal specimens also showed mixed results 
between the different groups. Due to the considerable differences in the magnitude of the 
tensile moduli, the only two-way ANOV A that was performed was on the radial 
specimens with leaflet section as one factor (AR vs. PR) and the 3 culture groups as the 
other factor. The two-way ANOVA analysis of tensile modulus for the radially oriented 
specimens did not detect a significant difference between experimental groups. The 
results did indicate a trend of lower tensile moduli in the static culture specimens 
compared to fresh specimens (p = 0.2974) and dynamically cultured specimens (p = 
0.0976) (Figure 4.11a). The pattern between groups was different for the stiffer AC and 
CH specimens (Figure 4.11 b). The fresh chordae had tensile moduli significantly greater 
than those from both the static (p = 0.0191) and dynamically (p = 0.0373) cultured 
valves. The AC specimens showed the same pattern, but without statistical significance. 
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Figure 4.11. Tensile elastic moduli. A) Radially oriented sections. B) AC and Ch sections. 
*: indicates significance, p < 0.05. 
Comparisons of extensibility between groups did not find any significant differences, 
whether analyzed as an overall pattern using a two-way ANOVA or within sections using 
a one-way ANOV A (Figure 4.12). Similarly, the stress relaxation time constants did not 
vary between treatment groups (data not shown), whether analyzed as an overall pattern 
using a two-way ANOV A or within sections using a one-way ANOV A. 
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Figure 4.12. Extensibility among all sections and treatment groups. 
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Histology and Immunohistochemistry 
A two-way ANOVA performed on laminar delineation grades of Movat-stained cross-
sections with section and treatment group as factorsdid not suggest any significant 
differences, nor did separate two-way ANOV As for each section type (Radially oriented 
vs AC/Ch). However, a trend in radially oriented sections suggested a decreases in 
average delineation grade from fresh valves to static and dynamic culture valves (Figure 
4.13a). The trend in the AC and Ch sections suggested an increase for static culture 
valves and a decrease for dynamic culture valves (Figure 4.13b). A two-way ANOV A 
indicated a significant decrease in the collagen staining intensity of all sections from 
dynamic culture valves compared to fresh valves (p = 0.0002) and static culture valves (p 
< 0.0001) (Figure 4.14 and Figure 4.15). This decrease was not seen in static culture 
samples. Grading of GAG staining intensity of radially oriented samples from fresh 
valves was found to be significantly greater (p < 0.0001) than that of static and dynamic 
culture valves (Figure 4.16a) .. The ANOVA for AC/Ch specimens detected no effect of 
experimental group, but the grading results did suggest a weak trend of decreased GAG 
intensity in static valves compared to fresh and dynamic culture valves (Figure 4.16b). 
Picrosirius Red images exhibited varying levels of staining brightness and collagen 
organization between sections and valve regions, but no statistically significant 
differences were detected between experimental groups (Figure 4.17). 
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Figure 4.13. Delineation grading of Movat stained tissue sections. A) Radially oriented 
sections. B) AC and Ch sections. 
Figure 4.14. Movat stained AC tissue sections. A) Freshly harvested valve. B) Static 
culture valve. C) Dynamic culture valve 
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Figure 4.15. Collagen intensity grading of Movat stained tissue sections. Significant 
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Figure 4.17 Picrosirius Red staining results. A-C) Brightness of collagen staining. D-F) 
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Figure 4.18. CD-31 staining by IHC. A) A 
valve surface with staining indicating an 
endothelial ceUlayer. B) An edge created by 
dissection without staining. 
Observation of CD-31 IRC sections confirmed continuous endothelial cell layers in all 
samples, from all groups. Figure 4.18 shows a valve surface with staining indicating an 
endothelial cell layer and a surface created by dissection without staining. 
Based on the separate patterns of hematoxylin statining intensity measurements (Figure 
4.19), these results were separated by section type and analyzed by two-way 
ANOV As.Within radially oriented sections, the three experimental groups were 
determined to have significantly different hematoxylin staining intensities (F > S, p = 
0.0289; S > D, p = 0.0229; F > D, p < 0.0001). Within AC and Ch sections, hematoxylin 
staining intensity in dynamic culture specimens was significantly less than fresh (p = 
0.0368) specimens. 
PCNA staining intensity in radially oriented sections of fresh valves was significantly 
greater than the corresponding sections in static culture valves (p = 0.0392) and showed a 
trend of being greater than the corresponding sections in dynamic culture valves (p = 
0.0524) (Figure 4.20a). PCNA staining in AC and Ch sections was consistent across 
experimental groups (Figure 4.20b). Caspase 3 staining intensity did not indicate any 
differences across groups (Figure 4.21). SMaA staining intensity (Figure 4.22) was 
analyzed by a two-way ANOV A and produced no significant results. Performing one-
way ANOV As for each section detected the SMaA staining intensity for the AC section 
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Figure 4.19. Hematoxylin staining intensity. A) Radially oriented sections. B) AC and Ch 
sections. Significant differences; *: p < 0.05, **: p < 0.0001. 
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Figure 4.20. PCNA staining intensity by IHC. A) Radially oriented sections. B) AC and 
Ch sections. *: indicates significance, p = 0.0392. 
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Figure 4.22. Smooth Muscle a-Actin staining 
intensity by IHC. *: indicates significance, p 
= 0.0365. 
of static culture valves was significantly less than (p = 0.0365) for fresh valves. Notably, 
the SMaA staining intensity of the AC section of dynamic culture valves was nearly 
equal to that of static culture valves. 
P4H staining intensity was analyzed throughout the tissue cross-sections as well as in 
valve regions (Figure 4.23). A one-way ANOV A performed across groups found that 
P4H staining intensity throughout the thickness ofPR sections of static culture valves 
was significantly less than the staining intensity in fresh valves (p = 0.0475). Each valve 
region was analyzed by a two-way ANOVA with tissue section and experimental group 
as the factors and no effects were detected so one-way ANOVAs were performed within 
each tissue section. Analysis of the free edge of AR sections found more intense staining 
in static culture valves than fresh valves (p = 0.0314). In the same regions, the average 
dynamic valve staining intensity was very similar to that of fresh valves. In addition to 
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these analyses, another two-way ANOV A, with experimental group and valve region as 
the factors, was performed within each valve section. This analysis found an effect of 
experimental group within AR sections, but post-hoc tests found no significant 
differences. In the AR sections the staining intensity in static culture valves suggested an 
increase compared to dynamic culture valves (p = .0626) or fresh valves (p = 0.0823). 
Decorin stained specimens were also analyzed through their full cross-section and within 
specific regions (Figure 4.24). None of the analyses found a significant effect of 
experimental group, but the average measured decorin staining intensity was greatest in 
the tissues from the dynamic control group in all measured valve regions. 
The results ofversican staining intensity analysis are shown in Figure 4.25. Two-way 
ANOVAs ofversican staining intensity separated by section type found an effect of 
experimental group within the AC/Ch sections. Post-hoc analysis found that staining 
intensity in fresh valves was significantly greater than dynamic culture valves (p = 
0.0171). No effects were found in an analysis of the staining intensity in the isolated 
valve regions. 
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*: indicates significance, p = 0.0171. 
A two-way ANOVA across sections and experimental groups indicated significant 
decreases in hyaluronan staining intensity in both the static (p = 0.0418) and dynamic (p 
= 0.0035) culture groups when compared to freshly harvested valves (Figure 4.26). 
Analysis of staining intensity in specific valve regions did not indicate significant 
differences. 
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Analysis of the negative control and hematoxylin-only slide images indicated differences 
in staining intensity. The average intensities (Mean ± SD) for Mouse secondary (54.6 ± 
12.8), Rabbit secondary (47.7 ± 12.8), and hematoxylin counterstain (39.8 ± 6.0) were 
compared by paired t-tests and found to have significantly different staining intensities (p 
< 0.0001). This confirmed the occurrence of consistent, low-level, non-specific binding 
of the secondary antibodies or other components of the staining procedure. 
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Discussion 
The analyses performed in this research study, taken together with the previous studies 
cited earlier, have demonstrated how the absence of mechanical stimulation (static 
conditions) are detrimental for the organ-level culture of mitral valves. After a culture 
period of three weeks, the most striking physical disparities between statically cultured 
valves and normal valves are the overwhelming loss of cellularity, increase in water 
content, decrease in GAG content, and thickening of the statically cultured valve tissues. 
These alterations demonstrate a major degradation ofthe tissue and likely influenced the 
measured mechanical properties. The dynamic mechanical environment provided by the 
mitral valve organ culture system prevented some of these changes over the same three 
week culture period, particularly maintaining cell content and hydration. As noted earlier, 
similar results have been reported from comparisons of static and dynamic culture 
environments, for example the greater degree of cell incorporation into the middle of 
polymeric tissue engineering scaffolds that were exposed to dynamic flexure vs. no 
flexure conditions (58). The opening and closing of the mitral valve in the organ culture 
bioreactor in this present study also induced flexure and stretch of the valve tissue, which 
likely allowed for the perfusion of culture medium into the valve tissue. 
The reduction in GAGs in both static and dynamically cultured valves suggested 
biochemically was confirmed by histology and immunohistochemistry, with both groups 
demonstrating loss of alcian-blue-staining hydrated GAGs and loss ofhyaluronan and 
versican during the culture period. In contrast, the abundance of the small PG decorin 
(whose GAGs do not commonly stain blue using Movat) was preserved in both culture 
groups. It has been previously demonstrated in engineered tissue constructs that cyclic 
63 
mechanical stimulation modulates the production of various types of GAGs and 
proteoglycans by mitral valve cells (30), and over time leads to a greater production of 
sulfated GAGs and lower production ofunsulfated GAGs by leaflet cells (29). Similar 
increases in the synthesis of sulfated GAGs were found in aortic valve leaflets subjected 
to cyclic hydrostatic pressure (33).The measured results did not meet the expectation that 
the dynamic culture environment would create this type of cyclic strain and pressure 
within the valve tissue and mitigate the GAG loss found in static culture. The retention of 
decorin and decrease in other GAGs is likely due to their specialization for tensile and 
compressive load-bearing functions, respectively (59) Increases in retrograde flow 
through dynamically cultured valves may have been associated with poor coaptation of 
the valve leaflets and a resulting reduction of compressive stresses in much of the valve. 
The calculated tensile moduli support the role of dynamic organ culture in maintaining 
native valve properties. The radially oriented sections showed a significant increase in the 
tensile moduli of dynamic culture valves compared to static culture valves, retaining 
similar properties as the radial sections of fresh valves. Biochemical measurement of 
collagen, the principle tensile-load bearing component, showed no difference between the 
dynamic and static culture leaflets, with both suggesting higher collagen concentration 
than leaflets from fresh valves. Conversely, the AC or Ch sections showed no difference 
in tensile moduli between dynamic and static culture valves; both showed decreases 
compared to fresh valves. In these tissues, collagen was not measured biochemically, but 
mc staining for decorin and P4H, markers associated with collagen and collagen 
synthesis, did not indicate any differences between fresh valves and either group of 
cultured valves. It is surprising that consistent levels of collagen concentration would be 
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found in tissues with such different tensile properties. However, these measurements of 
collagen concentration and synthesis do not indicate collagen types or fiber orientation. 
The decreases in tensile moduli may be accompanied by a shift towards more collagen 
III, which is common in heart valves but is less stiff than collagen I. In their native state, 
most collagen fibers in the AC and Ch sections are highly aligned along the axis of 
tensile loading used in this study (7,60). A distorted strain distribution through the valve 
could lead to non-alignment or misalignment of collagen fibers within these sections. 
This adverse remodeling could result in the demonstrated decreases in tensile moduli in 
static and dynamic culture. While the dynamic culture does maintain collagen 
concentration and tensile properties in radial leaflet sections, it does not maintain the 
mechanical properties of the AC and Ch sections. 
Comparisons of the dynamically cultured valves with freshly harvested mitral valves 
indicated many similarities but also some distinctive differences, such as in collagen 
content and associated mechanical behavior. We are currently evaluating these 
differences to guide our next generation of the organ culture system. For example, the 
differing effects of the dynamic culture environment on the tensile mechanical behavior 
of the valve sections may be explained by the way the chordae tendineae were mounted 
into the system, which could have subjected the various chordae to non-native stretch 
magnitudes. In vivo, the native chordae attach along the papillary muscles in the ventricle 
wall; we observed that this region of papillary chordal insertions may be as long as 2 cm, 
resulting in some chordae being anchored much closer to the valve leaflet than others. 
The current ex vivo system assembly, in contrast, holds all chordae at the same distance 
from the leaflets, which we believe improperly distributed stress through these chordae 
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and to the leaflets. Indeed, others have used ex vivo flow loops to demonstrate that 
different papillary muscle positions will affect leaflet strains and strain rates (61). This 
result could explain the trend of decreased tensile moduli in the chordal and 
circumferentially oriented leaflet tissues observed in the current study. 
In the future development of the organ culture bioreactor, a more natural configuration of 
the chordae tendineae and papillary head, together with associated motion during the 
systolic phase, should provide a more physiological distribution of stress through the 
chordae and leaflets, encouraging ECM regulation that more closely maintains native 
properties. This could be achieved by preserving the existing helical coils that wrap 
around the papillary muscles, but adapting their anchoring wires to angle away from the 
valve orifice. 
Another factor leading to less than optimal stress distribution and remodeling may have 
been the absence of both normal left ventricular suction and active atrial systolic 
pumping during the ventricular diastolic phase (62, 63). Modification of the fluid 
pumping system to provide this suction and pumping to fill the ventricular chamber, 
instead of the passive diastolic filling from the atrial reservoir, should also contribute to a 
more physiologically faithful organ culture system for the mitral valve. 
We attempted to validate the data from this study through comparisons with other 
published measurements, but as this is the first long-term organ culture study of the 
mitral valve, we were limited to comparing the data from group F (fresh controls) to other 
published measurements of heart valves. In terms of biochemical measurements, the 
concentrations of water and GAGs (hexuronic acid) were consistent with previously 
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reported values (6). The concentration of DNA in these porcine valves was greater than 
previously found in healthy human mitral valves (64), but that may have been expected 
as the human valves were from older adults and valve cellularity has been shown to 
decrease with age (56). The DNA content also compares well with amounts measured in 
porcine aortic valve tissue after only 48h of culture under various levels of hydrostatic 
pressure (22). With respect to physical and material properties, the thickness and elastic 
moduli ofthe leaflet samples closely matched previously reported values (56). The 
extensibilities for fresh control leaflets were slightly lower than previously reported in 
that work, but demonstrated a similar pattern of greater extensibility along the radial 
direction (0.16 ± 0.02 mmlmm) than along the circumferential direction (0.10 ± 0.03 
mmlmm) or in the chordae (0.10 ± 0.02 mm/mm). The stress relaxation parameters were 
also similar to (although slightly greater than) values for similar sections in the same 
prior study. The fmding that our control data were consistent with previously reported 
magnitudes and patterns gave us confidence in the authenticity of the data patterns from 
the dynamic and static organ cultured groups. 
In conclusion, despite some room for improvement, the mitral valve organ culture system 
described was able to maintain the cellularity of cultured valves through the use of a 
dynamic mechanical environment. This system provides an environment for studying 
valve biology that is more physiologically relevant than static organ culture and that 
integrates the structural organ-level interactions that are necessarily removed in cell 
culture studies. Such a tool can be of significant utility in investigating the causes 
of mitral valve disease. Chapter 5 demonstrates this capability. 
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Chapter 5 SIMVASTATIN INHIBITS ANGIOTENSIN-II INDUCED MITRAL 
V ALVE REMODELING IN AN Ex VIVO ORGAN CULTURE MODEL 
Introduction 
This chapter shifts focus from the development and testing of the organ culture system to 
its implementation as an experimental model. The aim, as introduced in Chapter 1, is to: 
Employ the organ culture system to study the ex vivo effects of Angiotensin IL alone and 
in combination with Simvastatin, on mitral valve tissue. 
Background 
The AHA estimates that in 2010, a 40-yr old man or woman has a 1 in 5 risk of 
developing heart failure (HF) within their lifetime (1). This widespread disease, in which 
the heart's ability to pump blood is reduced and thus it cannot meet the body's needs, 
generally occurs in the left heart. It begins with an initial ailment, commonly 
hypertension or myocardial infarction, decreasing the ventricular ejection fraction. The 
resulting ventricular dilation further decreases the myocardium's force of contraction. 
The disease can also develop towards hypertrophy as the heart remodels to impede the 
dilation. In either case, the heart is weakened, contributing to progression of the disease 
state. 
During HF, a host of vasoactive agents are found in the bloodstream in elevated levels, 
including angiotensin II (All), part ofthe renin- angiotensin System that is meant to 
regulate total blood volume and pressure (65). In addition to being a potent 
vasoconstrictor, All has also been found to affect the turnover of extracellular matrix 
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(ECM) molecules in cardiovascular cells. An in vitro study of human cardiac fibroblasts 
demonstrated an increase in collagen synthesis caused by All (66). All acted to stimulate 
incorporation of proline, a major component of collagen, with effects maximized with a 
All concentration of 10 nM to 10 J.l.M. Blocking the angiotensin type-I receptor (AT-I), 
but not type-2 receptor (AT -2), inhibited these effects. 
The valves of the heart show signs of dysfunction in the development and progression of 
HF. A study of dilated cardiomyopathy found mild to severe mitral regurgitation (MR) in 
a majority of cases (67). The effects ofMR often further contribute to the decline in 
cardiac output. MR can occur either as a result of defects within the valve (known as 
organic MR), or as functional MR, in which the valve is anatomically healthy but 
dysfunctional because of external factors such as changes to cardiac anatomy. 
Determining the cause of MR is important because the most effective treatment differs 
based on the underlying cause (67). In cases of dilated cardiomyopathy, cardiac 
remodeling displaces papillary muscles and dilates the valve annulus. These geometric 
alterations pull apart the valve leaflets, preventing ideal leaflet coaption (68). 
Additionally, elevated levels of All and other hormones associated with HF may cause 
pathological remodeling in the mitral valve leading to MR, although the effects of such 
altered blood chemistry on valves have received little attention. Mitral valves from HF 
patients demonstrated increased cell, glycosaminoglycan (GAG), and collagen content as 
well as decreased tissue hydration seemingly resulting from altered cardiac geometry 
(64). Based on this altered anatomy, the MR found in HF does not appear to be 
functional, but it is unclear as to the relative effects of mechanical- and biochemical-
based remodeling. 
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Statins, also known as HydroxyMethylGlutaryl Coenzyme A Reductase Inhibitors, are 
effective in reducing high cholesterol (69, 70) and are attributed with additional benefits 
in treating a variety of cardiovascular diseases (71), including heart failure (72, 73) and 
for selected patients with valve disease(74). Statins have also been shown to decrease 
vascular fibrosis caused by All (75) and would be a good candidate to prevent adverse 
All-induced valve remodeling. 
With the pathogenesis ofMR only now being adequately investigated, prevention is not 
yet feasible and treatments have, until recently, been limited to surgical interventions 
(76). The current study investigates the possible role of All in pathological remodeling of 
the mitral valve. Further, simvastatin is evaluated for any ability to inhibit any effects of 
All, as a representative of the class of statin drugs. In order to provide a culture 
environment more physiologically appropriate than a cell culture study, we utilized the ex 
vivo organ culture system described and characteriezed in Chapter 3 and Chapter 4. This 
system provides a physiological level of mechanical stimulation and helps to maintain 
cultured mitral valves in a more native state, most notably retaining high levels of cell 
viability. 
Materials and Methods 
Organ Culture System 
Details of the assembly and function of the mitral valve organ culture system have 
already been described. In brief, the system is a mock circulation consisting of three 
major components: a "ventricular" pumping chamber that housed the porcine explant 
valves, a compliance chamber that conditioned the flow response, and a raised and vented 
70 
reservoir that supplied an "atrial" filling pressure. An electronic pressure regulator 
created a pneumatic pumping action through a silicone diaphragm. The pulsatile pressure 
waveform was controlled by a Virtual Instrument created with LabView software 
(National Instruments, Austin, TX) and configured with a peak of 120 mmHg and 
frequency of 60 beats per minute. 
Harvest, Preparation, and Culture of Valves 
The harvest and preparation of the mitral valves and the culture system assembly were 
performed with the procedures described in Chapter 4. 
Each treatment group used approximately 1.4 L M199 culture medium, supplemented 
with 10% Bovine Growth Serum (BGS, Thermo-Hyclone, Logan, UT) and 1% anti-
microbial solution. The Control group (CTRL, n=5) had no extra supplement. The All 
Low group (AL, n=4) was supplemented to include 10 nM All (EMD Chemicals, 
Gibbstown, NJ). The All High group (AH, n=4) was supplemented with 10 ~M All. The 
Simvastatin group (Sim, n=4) was supplemented with a 10 ~M dose of All and 10 ~M of 
Simvastatin (EMD Chemicals). These concentrations were chosen based on 
concentrations previously shown effective in vitro (66, 75, 77-79). The entire system was 
maintained in a humidified incubator at 37° C and 5% C02 for 21 days; the culture 
medium was drained and replaced every 7 days. Previous studies of both All (80) and 
simvastatin (81) have confirmed their stability in the heated environment for this 
duration. Pressure within the ventricular chamber and flow rates just upstream from the 
mitral valve were recorded throughout the culture period. Flow measurements of full 
pumping cycles were selected from five time points during each valve's culture: Days 1, 
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4, 7, 14, and 21. The total flow rate was calculated by integrating the instantaneous flow 
rate. Forward flow was calculated from the integral of all positive flow values and 
retrograde flow from the integral of all negative flow values. 
After the 21 day culture period, the valves were removed from the organ culture system 
and prepared for analysis. The valves were each photographed and then dissected into 
seven sample sections. These sections were identified as: anterior leaflet radial strip 
(AR), anterior leaflet circumferential strip (AC), two anterior strut chordae (Ch), the 
remaining anterior leaflet tissue (Ant), posterior leaflet radial strip (PR), and the 
remaining posterior leaflet tissue (Post). While the Ant and Post sections were used for 
biochemical analyses, the other sections were reserved for material testing and were 
subsequently prepared for histological analyses. Note that the remaining chordae were 
dissected from the leaflet samples. 
Biochemical Analyses 
Biochemical assays were performed on each Ant and Post specimen according to the 
procedures described in Chapter 4. These assays measured water, DNA, GAG, and 
collagen content. 
Materials Testing 
Uniaxial tensile load-elongation tests were performed on each AC, AR, PR, and Ch 
specimen according to the procedures described in Chapter 4. Equipment faults rendered 
stress relaxation data unusable due to sample size. 
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Histological and Immunohistochemical Staining 
After tensile testing, the sections were immersed in formalin overnight, dehydrated using 
a series of graded alcohols, soaked in xylene, and embedded in paraffin blocks according 
to standard procedures for histological processing. The tissue blocks were then sliced into 
5 )..lm thick cross-sections and set onto positively-charged glass slides. Tissue cross-
sections were stained with a Movat Pentachrome to visualize ECM and the leaflet 
structure. Samples were also stained with Picrosirius Red to observe collagen fiber 
alignment as described in Chapter 4. An Alizarin Red stain was applied to indicate the 
extent of any calcification, which would be marked by dark red staining over the pink 
background. 
Immunohistochemical (IHC) staining was also used to localize several markers of cell 
and tissue phenotype. mc was performed according to standard procedures involving 
primary antibodies that demonstrate valve cell phenotype or tissue ECM composition 
(Table 5.1), biotinylated secondary antibodies (Jackson Immunoresearch, West Grove, 
P A), visualization via a chromogen reaction, and a nuclear hematoxylin counterstain. In 
order to control for non-specific binding, negative controls for each secondary antibody 
were performed with no primary antibody on every specimen. In addition, a set of 
hematoxylin-only slides were prepared to quantify nuclear staining. 
Three markers were stained to investigate the modulation of valve cell phenotype. The 
All type-l receptor (AT -1) was selected because it has been found to mediate increased 
synthesis of collagen in human cardiac fibroblasts (66). It has also been found by 
immunohistochemistry in greatly elevated levels in sclerotic aortic valves, co-localized 
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Table 5.1. Immunohistochemistry Markers. Sources: A) Abeam, Cambridge, MA. B) Lab 
Vision, Fremont, CA. C) A gift from Dr Larry Fisher, NIH. D) Associates of Cape Cod, East 
Falmouth, MA. HA is detected using biotinylated HA Binding Protein in place of a primary 
and secondary antibody. E) Millipore, Billerica, MA. F) Dako, Carpinteria, CA. G) 
BioVision, Mountain View, CA. 
Secondary Antigen 
Marker Dilution Antibody Retrieval Relevance 
Angiotensin II 1:200 Mouse Citric Acid - Mechanism for All 
Receptor 1 (AT-l)A 
Heat Mediated 
effects, elevated in 
sclerotic valves 
CD-31 B 1:50 Rabbit Citric Acid - Endothelial cell marker 
Heat Mediated 
Collagen I1Ic 1:500 Rabbit None Collagen sub-type 
Decorinc 1:500 Rabbit Chondroitinase Collagen formation and 
ABC organization 
HyaluronanD 1:250 N/A None Located in areas of 
compressive loads 
Prolyl-4- 1:200 Mouse Citric Acid - Enzyme marker of 
Hydroxylase 
Heat Mediated 
collagen synthesis 
(P4H)E 
Smooth Muscle u- 1:1000 Mouse Citric Acid - Valve cell activation, 
Actin (SMuAl localized in valve 
Heat Mediated lesions 
Transforming 1:20 Rabbit Citric Acid - Downstream All 
Growth Factor-~ 
Heat Mediated 
product, increases 
(TGF-~)G collagen, biglycan 
synthesis 
VersicanD 1:500 Mouse Chondroitinase Located in areas of 
ABC compressive loads, 
disrupted in valve 
disorders 
with Smooth Muscle a-Actin (SMaA) (82). SMaA was also selected for mc staining 
and is a marker for 'activated' valve interstitial cells found in developing, diseased, and 
otherwise remodeling mitral valves (18,83). Increased SMaA expression has been shown 
to occur in vitro after the addition of Transforming Growth Factor-~ (TGF-~), an effect 
that is inhibited by simvastatin (78). TGF-~ was also selected for mc staining because it 
is a downstream product of All, mediated by AT-l (84). TGF-~ has been implicated in 
the formation of valvular lesions in part because it induces increased production of 
sulfated GAGs and hyaluronan from aortic valve cells (85). These three markers were 
examined together to detect phenotypic modulation of valve cells under the prescribed 
culture conditions and to attempt to explain mechanisms for any resulting ECM 
modulation. 
Collagen was the focus of another three IHC markers. Prolyl-4-Hydroxylase (P4H) is an 
enzyme involved in the early stages of collagen synthesis (86). More intense P4H 
staining is suggestive of increased collagen synthesis. Collagen I and III are the two 
major collagen subtypes found in valve tissues (87). Collagen III content can vary 
independently of collagen I and mc staining can indicate regional distributions of 
collagen III within the valve. Decorin is a Small leucine-rich proteoglycan (SLRP) that 
mediates the formation and organization of collagen fibrils (88) and its core protein has a 
binding site for TGF-~ (89). 
Hyaluronan is a large GAG molecule and versican is a large PG. Both molecules can bind 
substantial volumes of water and they are found in valve regions that typically experience 
compressive stresses (6). These markers were evaluated using mc to detect major 
changes in ECM composition and because their regional distribution can be indicative of 
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valve disorders (90). It should be noted that the procedure for staining hyaluronan does 
not involve primary and secondary antibodies but rather the biotinylated Hyaluronan 
Binding Protein (HABP). 
After completing staining procedures, most slides were digitally scanned at 7200 dpi with 
a PathScan Enabler IV slide scanner (Meyer Instruments, Houston, TX) to facilitate 
digital and observational image analyses. The Picrosirius Red slides were instead imaged 
with a microscope system (Leica DMIL, Buffalo Grove, IL) under polarized light. Radial 
sections were imaged at the valve insertion, mid-leaflet, and at the free-edge. They were 
then analyzed semi-quantitatively for staining brightness and the uniformity of collagen 
alignment and sorted into four grades for each characteristic. Movat-stained sections 
were randomized and analyzed using a semi-quantitative scale for distinct delineation of 
the layered structure, abundance of saffron-stained collagen, and abundance of alcian 
blue-stained GAGs (57). Every specimen was graded on a scale of I to 4 for each 
attribute. Slide images from mc were analyzed to measure the relative staining intensity 
of each marker throughout the tissue cross-section. Calculation of average staining 
intensity was automated with a batch macro in ImageJ (NIH, Bethesda, MD) that utilized 
particle analysis to isolate tissue sections from the image background. The resulting value 
was a measurement, ranging 0-255, of the average staining intensity of the region 
analyzed within each cross-section. 
Statistical Analysis 
Statistical calculations were performed using JMP software (SAS, Cary, NC). Average 
values were calculated and are expressed here as mean ± SE. Each data set was analyzed 
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by two-way ANOV A, separating specimens by both treatment group and valve section. 
Data sets were also analyzed by one-way ANOV A across treatment groups when results 
were inconsistent across valve sections. In certain cases, sections were separated into 
radially oriented (ARlPR) and AC/Ch "section types" that share similarities in typical 
loading and structural characteristics. Separate two-way ANOV As were performed on 
each section type across section and experimental group. A Tukey's test was used for 
post-hoc analysis with a level of significance set at 0.05. 
Results 
Flow Measurements 
Average flow measurements varied among the experimental groups but demonstrated the 
same trends (Figure 5.1). A two-way ANOVA comparing time points and experimental 
groups found that average forward flow generally increased a very small amount after 21 
days, from 2.62 ± 0.10 Ltmin to 2.86 ± 0.06 Llmin. Over the same period, retrograde 
flow immediately increased significantly, from 0.66 ± 0.09 Llmin on day 1 to 1.06 ± 0.09 
Llmin on day 4 (p = 0.0140) and to 1.37 ± 0.10 Llmin on day 21 (p < 0.0001). Due to the 
greater increase in retrograde flow than forward flow, total flow decreased, also 
significantly, from 1.96 ± 0.13 Llmin to 1.49 ± 0.12 Llmin (p = 0.0194). Between 
groups,the two-way ANOV A detected a significantly lower retrograde flow for AL 
samples than Sim (p = 0.032) or AH (p = 0.02) and significantly greater total flow for AL 
samples than Sim (p = 0.02), AH (p = 0.0054), and CTRL (p = 0.0014). The same 
analytical techniques suggested no differences between the peak ventricular pressures of 
77 
the selected pumping cycles. The overall average peak pressure was 108.7 ± 0.8 mmHg, 
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Figure 5.1. Flow Characteristics. A) Total (net) flow rate through the mitral 
valve. B) Forward flow rate through the mitral valve into the ventricular 
chamber. C) Retrograde flow rate from the ventricular chamber back through 
the mitral valve. D) The peak pressure reached in the ventricular chamber 
during the pumping cycle. #: Significantly different than aU other comparison 
sets, p < 0.014. *: Indicates significant difference, p < 0.0313. 
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Table 5.2. Thickness (mm) of Valve Sections in Different Groups. 
Tissue 10 /lM All + 
Section Control 10 nM All 10 /lM All 10 /lM Simvastatin 
PR 1.2±0.1 1.3±0.1 1.4 ± 0.1 1.4 ± 0.1 
AR 1.4±0.1 1.3 ± 0.1 1.2±0.1 1.4 ± 0.2 
AC 1.3±0.1 1.3 ± 0.1 1.4±0.1 1.3 ± 0.1 
Ch 1.4±0.1 1.4±0.1 1.3±0.1 1.2 ± 0.1 
Macroscale Anatomy 
The photographs of valves taken immediately upon removal from the organ culture 
system did not suggest any macro scale differences in the valve groups. The same is true 
for thickness measurements taken prior to materials testing (Table 5.2). No significant 
differences in thickness were detected across experimental groups by I-way ANOV A. 
Biochemical Analyses 
A two-way ANOVA performed on the results of the biochemical assays measuring DNA 
content and tissue composition did not reveal any statistically significant differences 
between groups (Figure 5.2). These collective analyses suggested increases in collagen 
content (p = 0.0931) and DNA content (p=0.1645) and decreases in GAG content (p = 
0.1553) as a result of dose-dependent responses to AngIl and the corresponding inhibitive 
effects of Simvastatin on collagen content (p = 0.1215) and GAG content (p = 0.1673). 
There were no significant differences in tissue hydration. This same data is detailed in 
Table 5.3Error! Reference source not found .. 
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Figure 5.2. - Biochemical Assay Results. The values for the Ant and Post sections were not 
statistically different and were grouped together for analysis. A) Average hydration. B) 
A verage collagen content, based on measurement of hydroxyproline. C) Average 
glycosaminoglycan (GAG) content, based on measurement of uronic acid. D) Cellularity, 
based on measurement of DNA. 
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Table 5.3. ECM Composition and DNA Content by Treatment Group. Anterior and 
Posterior sections are grouped together. 
10 ~MAII+ 
Control 10 nM All 1 0 ~M All 1 0 ~M Simvastatin 
Hydration (% wet wt) 88.4 ± 0.7 86.9 ± 0.7 86.7 ± 0.6 87.0 ± 0.9 
Collagen (% dry wt) 51.6 ± 3.1 56.3 ± 4.2 64.2 ± 3.9 51.7 ± 3.7 
GAG content (~g/mg dry wt) 6.36 ± 0.85 5.63 ± 0.60 4.43 ± 0.40 6.42 ± 0.43 
DNA content (~g/mg dry wt) 6.87 ± 1.10 8.93 ± 1.05 10.92 ± 2.05 8.59 ± 1.27 
Materials Testing 
Because of the evident differences in both the scale and patterns of tensile modulus 
results, the data from radially oriented sections was analyzed separately from the AC/Ch 
sections (Figure 5.3). When the radial sections were considered together in a two-way 
ANOVA across group and section the tensile modulus of the Sim group radial sections 
(5.9 ± 2.1 MPa) was found to be greater, though not significantly, than that of the AL 
group radial sections (2.6 ± 0.3 MPa, p = 0.1423). A two-way ANOV A performed on 
data from AC and Ch sections suggested as trends that the tensile moduli of Sim 
specimens (85.9 ± 19.1) was greater than CTRL specimens (41.6 ± 8.0, p = 0.0630) and 
AH specimens (48.2 ± 10.6, p = .1891). 
Extensibility measurements demonstrated a much stronger pattern of results (Figure 5.4). 
A two-way ANOV A across section and group was performed on this data. The All low 
dose (AL) samples did not demonstate any difference from CTRL samples. The high 
dose (AR) samples, however, did demonstrate a significantly greater average 
extensibility (0.168 ± 0.013) than the CTRL (0.114 ± 0.009, p = 0.0005) and AL (0.112 ± 
0.011, P = 0.0012) samples. The extensibility ofSim samples (0.133 ± 0.010) did not 
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demonstrate a significant difference with any other treatment group, but data suggested 
that the Sim treatment reversed the increased extensibility of AH samples (p = 0.1743). 
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Histology and Immunohistochemistry 
Because of the disparate patterns in different tissue sections, the Movat results were 
analyzed separately by one-way ANOV A. Grading of layer delineation in Movat-stained 
group (data not shown). The grading of saffron collagen staining demonstrated 
significantly increased collagen intensity in the chordae when treated with increasing 
concentrations of angiotensin II (p = 0.0245). A strong trend suggested inhibition of this 
increase associated with the addition ofsimvastatin (p = 0.0514) (Figure 5.5a). The 
grading of Alcian Blue GAG staining suggested two contrasting effects (Figure 5.5b). 
Among the radial sections, GAG staining in the Sim specimens was less intense than 
CTRL specimens (p = 0.1082). A one-way ANOV A found that this relation was 
significant when limited to only PR samples (p = 0.0457). Among AC and Ch specimens, 
GAG staining was increased in the Sim group, compared to AH (trend, p = 0.1296). 
Alizarin Red staining did not indicate any calcific nodes in any samples. 
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Figure 5.5. Movat Grading Results. A) Saffron staining for collagen. B) Alcian Blue staining 
for GAGs. Movat-stained sections were graded on a 1-4 scale for each property by a blinded 
observer. *: Indicates significance, p < 0.0457. 
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Picrosirius Red images exhibited varying levels of staining brightness and collagen 
organization between sections and valve regions, but no statistically significant 
differences were detected between experimental groups (Figure 5.6). 
A one-way ANDV A of collagen III mc in PR sections suggested that the staining 
intensity of AH samples was less than CTRL samples, although this was only a trend (p = 
0.0849). A two-way ANOV A within the AC/Ch section type demonstrated that collagen 
III staining was significantly less intense in Sim samples than CTRL samples (p = 
0.0026). Trends in the same analysis suggested Sim staining was also less than AL (p = 
0.1075) and AH (p = 0.1109). The collagen III intensity results are shown in Figure 5.7. 
mc staining for decorin, P4H and SMaA produced no significant or notable results 
(data not shown). 
IHC staining for neither AT -1 nor TGF -p produced significant results or patterns 
consistent between tissue groups (data not shown). However, these markers were co-
localized and the intensity results of the two markers appeared to match each other well 
(Figure 5.8a). Performing a linear regression on the two data sets confirmed the moderate 
correlation (R2 = 0.47, Figure 5.8b). 
Statistical analysis of staining for hyaluronan indicated no significant differences in 
intensity between the All-treated groups and the control group. HA staining in the Sim 
group waS significantly less intense than all other groups (p < 0.001). Again, this 
comparison is most clear with all tissue sections grouped together (Figure 5.9a). 
Hyaluronan staining intensity was also measured in specific regions of the radially 
oriented sections: the fibrosa, spongiosa, and free-edge (Figure 5.9b&c). These region-
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Figure 5.8. A) IHC staining of Angiotensin II Receptor I (left) and TGF -~ (right). The 
staining patterns indicate co-localization of these markers. B) Linear regression correlation 
AT-l and TGF-~ staining intensity (R2 = 0.47). 
specific measurements confirmed the results of the more general intensity measurements. 
A two-way ANOVA across sections and groups demonstrated that, in the fibrosa, 
hyaluronan staining intensity of CTRL was significantly greater than Sim (p = 0.0098). 
Further, the free-edge region of PR sections showed significantly increased staining 
intensity in AL (p = 0.0128) and AH (p = 0.0083) specimens, compared to Sim. In 
addition, a three-way ANOVA was performed on the region-specific data, comparing 
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results across section, group, and region. This analysis found that the Sim regional 
staining intensity ofhyaluronan was significantly less than all other experimental groups 
(p < 0.003). Versican staining intensity results indicated divergent patterns between 
sections, so the tissue sections were analyzed separately. In the radial sections, AR and 
PR (Figure 5.1 Oa), the staining intensity in the CTRL group was significantly greater than 
for AL (p = 0.0409) and Sim (p < 0.0001). In addition, radial section staining in AH was 
significantly greater (p = 0.0211) than Sim. Among AC and Ch sections (Figure 5.10b), 
the most intense versican staining was in the AL group, which stained more strongly than 
for the Sim group (p = 0.0291) or the CTRL group (0.0365) . 
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Figure 5.9. Hyaluronan Staining Intensity. A) Intensity measured as an integral of the 
entire tissue cross-section. B) Intensity measured in specific valve regions of AR sections. 
C) Intensity measured in specific valve regions of PR sections. Significance: *, p < 0.0128; 
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A two-way ANOV A, across group and valve section, determined an effect of 
experimental group on hematoxylin staining intensity as an indicator of cell density 
(Figure 5.11). Post-hoc analysis found significantly more intense staining for both the 
low (p = 0.0298) and high (p = 0.0012) concentrations of All, compared to CTRL. 
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Further, the Sim group had an average staining that was comparable to CTRL and 
significantly less intense than the AH samples ( p = 0.0037). 
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Discussion 
This study investigated the role of All, a chemical overly abundant in the blood of heart 
failure patients, on mitral valve remodeling in vitro; the results suggest an increase in 
cellularity, a decrease in GAG content, a minor increase in collagen content, and 
decreased hydration. A previous study examining the effects of HF on human mitral 
valves without apparent MR found increases in all three components and a decrease in 
hydration (64). The prior study had concluded that the ECM remodeling was indirectly 
caused by cardiac remodeling and dilation. Dilation can change the stress distribution 
within the valve, even without precipitating MR, and leading to adverse valve 
remodeling. By controlling for any altered mechanical environment, the current study 
shows that at least some of the valvular tissue remodeling is the result of tissue responses 
to the biochemical changes accompanying HF. Given the number of other hormones 
elevated in HF, including Endothelin-l, Transforming Growth Factor-~, Vasopressin, 
Tumor Necrosis Factor-a, Norepinephrine, and others, there is good reason to believe in a 
strong role of altered blood chemistry in mediating valve remodeling. 
The biochemical PicoGreen assay suggested that valvular DNA content increased with 
increasing All concentration. Hematoxylin staining for cell nuclei also increased with 
increasing All cot;lcentration. Both of these effects were inhibited by the addition of 
Simvastatin to the culture medium. These results show that All induces valvular cell 
proliferation and that Simvastatin inhibits this effect. Previous studies have demonstrated 
that All induces cell proliferation in vitro in sheep cardiomyocytes (91) and rat cardiac 
fibroblasts (92, 93) through an Endothelin-l mediated pathway. Our results show a 
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similar effect in cultured porcine valvular tissue, an effect which may also act through 
endothelin-l. 
Measurement ofuronic acid content suggested a decrease in GAG content induced by All 
and inhibited by simvastatin. In the case ofversican, the All-induced decrease was 
confirmed through me in radial sections, but the addition of simvastatin further 
decreased staining intensity. Staining intensity ofhyaluronan also showed somewhat 
contrary results with the addition of simvastatin. Staining of decorin did not indicate any 
changes in staining intensity with any treatment. To clarify these results, more sensitive 
techniques are needed that encompass a larger span of PGs, such as biglycan, the 
production of which has been found to be induced by All in vitro (94). 
The hydroxyproline assay showed an increase in collagen content associated with 
incubation with All. This increase was inhibited by the addition of simvastatin. This 
pattern was reflected by grading of collagen staining in Movat stains of radial and chordal 
specimens and suggests that All induces collagen synthesis in porcine valve cells, as has 
been shown for rat cardiac fibroblasts (95) and human cardiac fibroblasts (66). The 
inhibitive effect of simvastatin was also expected. Collagen III staining was found to 
decrease with the addition of simvastatin. This suggests that, while simvastatin inhibits an 
increase in total collagen content, it may also cause a shift in the proportion of collagen 
types present in the valve. 
Remodeling of the major ECM components of valve tissue should be indicative of the 
tissue's material properties. In this case, the increases in tensile modulus in the AL and 
AH treatment groups compared to controls may be a function of increased collagen 
91 
content, though the Sim group also showed a larger increase in tensile modulus without 
an increase in total collagen. Since Sim also tended to have lower collagen III staining 
intensity, it is possible that the increase in tensile modulus was due to a shift from 
collagen III to collagen I, which results in stiffer tissue along the fiber orientation. 
Extensibility is dependent on the ability of collagen fibers to straighten out their natural 
crimp before bearing larger loads. The increase in extensibility of AH and AL specimens 
compared to controls may relate to changes in collagen organization or orientation. 
The addition of All to the culture medium resulted in increased cellularity. A SMaA-
positive phenotype is associated with the adverse valve remodeling of myxomatous valve 
disease and the development of valvular lesions. While the current data was inconclusive, 
it is likely that an increase of SMaA-positive cells is a mechanism for the demonstrated 
effects of All on cultured valves and a mechanism through which elevated blood levels of 
All during HF contribute to the development of valve disorders. In a previous study, 
TGF -(3 induced SMaA expression in aortic valve cells was inhibited by the addition of 
simvastatin through a Rho-mediated pathway (78). A similar effect was not demonstrated 
in this study. 
Several factors served as limitations regarding the results of this study. Analysis ofthe 
negative control and hematoxylin-only slide images indicated small differences in 
staining intensity. The average staining intensities were appreciable for mouse secondary 
(47.3 ± 1.2), rabbit secondary (41.5 ± 0.8), and hematoxylin counterstain (38.1 ± 0.6). 
This confirmed the occurrence of minimal, but consistent, non-specific binding of the 
secondary antibodies or other components of the staining procedure. In addition, the 
significant differences between the flow characteristics of experimental groups may have 
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influenced the mechanical stimulation experienced by cultured valves. However, few of 
the significant results follow patterns similar to the magnitudes of total flow or retrograde 
flow, suggesting that these effects are overwhelmed by the biochemical effects of All and 
simvastatin. Also, the current study found only diffuse AT -1 and TGF -~ staining, perhaps 
because the lack of circulating lipoproteins and macrophages precluded the development 
of inflammation or because the 3 week culture period was not a long enough time to 
develop the conditions for localization. Additionally, localization of AT -1 may be 
prompted by All synthesis by localized angiotensin converting enzyme (ACE). 
In conclusion, the results of this study show that angiotensin II modulates ECM synthesis 
and turnover and increases cellular proliferation in mitral valve tissue. Also, simvastatin 
inhibits some of the effects of angiotensin II on mitral valve tissue and produces further 
effects on mitral valve tissue, both exaggerating some of the effects of angiotensin II and 
affecting properties unaltered by angiotensin II. These findings demonstrate that the 
pathologic ECM remodeling of mitral valves during heart failure is at least partially due 
to biochemical responses that do not rely on an altered mechanical or geometric 
environment. Additionally, this study has also demonstrated the utility of the mitral valve 
organ culture system in conducting relevant, novel, and unique ex vivo experiments. 
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Chapter 6 CONCLUSIONS, DISCUSSION, AND FUTURE DIRECTIONS 
In the overview (Chapter 1), we hypothesized that a physiological mechanical 
environment would help maintain the native characteristics of mitral valves in organ 
culture and serve as a novel experimental paradigm. In order to test this hypothesis, a 
mitral valve organ culture system was developed, characterized, validated, and 
implemented in a novel experiment according to the specific aims: 
Design and mechanically characterize a mitral valve organ culture system 
capable of reproducing the valve's physiologic mechanical environment. 
Further develop the organ culture system to integrate a porcine mitral valve in a 
sterile environment with adequate oxygen and nutrients. Evaluate the cultured 
valves to determine the effect of the dynamic mechanical environment. 
Employ the organ culture system to study the ex vivo effects of Angiotensin IL 
alone and in combination with Simvastatin, on mitral valve tissue. 
The previous chapters described in detail the process of completing these aims as well as 
the results and outcomes. 
Aim 1 Conclusions 
While the design process is documented in Appendix A, Chapter 3 describes the resulting 
design of a computer controlled flow loop system powered by a pneumatic bladder pump. 
Characterization of the system determined that it could create a ventricular pressure pulse 
with a physiologically relevant pressure range and a pulsatile flow rate nearing a 
physiological average. Sterility tests confirmed the system's resistance to contamination 
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when filled with culture medium. This characterization was a crucial step in testing the 
hypothesis: We needed to produce a physiological mechanical environment in order to 
determine the effect of that environment. Satisfactory completion of this aim allowed 
further development and testing of the organ culture system. 
Aim 2 Conclusions 
The second aim addressed biological design issues and tested the biological effectiveness 
of the system in conducting the organ culture of a mitral valve. A valve attachment 
technique was able to satisfactorily integrate a porcine valve into the organ culture 
system and allow it to open and close with each cycle. At the beginning of each 
experiment, the valve opened and closed properly, as was demonstrated by the recorded 
pressures and flow rates. Compared to a static culture environment, this dynamic 
environment greatly increased cell viability and maintained tissue hydration in the 
leaflets. However, the resulting leaflet ECM composition resembled that of statically 
cultured valves. Retrograde flow increased during the culture period, likely indicative of 
incomplete leaflet coaptation. Material properties of some tissue sections were 
maintained at native levels, but others were not. This discrepancy is possibly the effect of 
unnatural stress distributions. These separate properties that failed to retain native 
physiological values during dynamic culture are likely related, though the root cause is 
unclear. Despite these drawbacks, the organ culture system succeeded in helping to 
culture viable mitral valve tissue, fulfilling the first condition of the global hypothesis. 
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Aim 3 Conclusions 
The final aim used the organ culture system developed in the first two aims to study the 
ex vivo response of mitral valves to Angiotensin II, both alone and in combination with 
Simvastatin. Effects of Angiotensin II were generally dose-dependent and suggested the 
development of a more fibrous tissue. Cell content was also increased. Simvastatin 
treatment did inhibit many of these effects, returning the valve to a more natural 
composition. However, Simvastatin altered some other tissue characteristics that 
Angiotensin II did not, and some Angiotensin-II induced effects were exaggerated by the 
addition ofSimvastatin. This study showed that Angiotensin-II has the potential to induce 
pathologic valve remodeling and that the preventative or reactive use of statins would 
also have potential for adverse effects. By producing these results, the organ culture 
system has demonstrated its validity as a novel experimental paradigm and fulfilled the 
second condition of the universal hypothesis. 
Impact/Importance of Work as a Whole 
Ex vivo organ culture will provide many benefits and opportunities in the study of valve 
biology. This is partially because mechanical stimulation elicits cellular responses and 
also can modulate the responses of cells to other stimuli (88). In addition, valve cells 
modulate their behavior based on their environment - the presence of multiple cell types 
(25) and the composition of the surrounding matrix (96). This is the first published organ 
culture system for mitral valves and provides the paradigm to investigate the natural 
behavior of valve cells and their impact on mitral valve tissue in a way that is only 
matched or surpassed by animal models, but without the limitations or costs associated 
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with animal research. The work in this thesis has shown that the system can maintain 
biologically relevant tissues and produce valuable insights into heart valve biology. 
Limitations 
The completion of the three aims has revealed limitations in the studies described as well 
as in the organ culture system design. 
While Aims 2 and 3 allowed continuous flow and pressure measurements, the more 
meaningful results were the product of destructive assays and were limited to a single 
time point per valve. In order to boost statistical power and allow time for valve 
remodeling to progress, all dynamic culture periods lasted 21 days. While this did allow 
for meaningful results, the chronological effects of dynamic culture and biochemical 
additives remain unknown. Some additional information may be gleaned by frequently 
collecting and analyzing medium samples for molecules secreted by cultured valves. But, 
the large volume of medium may over-dilute any quantitative assay. 
In Aims 2 and 3, mc was intended to give a more detailed analysis ofECM remodeling 
than the aggregate quantification provided by the biochemical assays. However, due to 
the limitations of tissue availability, cost, and time, it was not possible to stain for all 
relevant markers. As a result, the distributions of big lycan, matrix metalloproteinases 
(MMPs), tissue inhibitor ofMMPs (TIMPs), collagen I, collagen III (Aim 2 only), and 
other molecules that may have provided answers to the remaining questions, were not 
investigated. An alternative would be to create less uncertainty by focusing on a narrower 
set of effects, such as collagen remodeling, and choosing markers to investigate the 
synthesis, sub-types, degradation, and associated molecules (such as decorin). 
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Dosage optimization was not performed to determine the Angiotensin II and Simvastatin 
concentrations for Aim 3. Instead, concentrations were based on previously published 
work. It is possible that these concentrations were too low, too high, or in the wrong 
proportion to stimulate relevant responses. It would be difficult to study a higher number 
of concentrations because ofthe difficulties of obtaining large sample sizes in this organ 
culture system. In vitro dosage optimizations may mitigate this limitation, but in vitro 
behavior may not accurately predict ex vivo behavior. 
The organ culture system developed in this research is limited by its capacity to generate 
large sample sizes. The current implementation allows only two valves to be cultured at a 
time, while occupying nearly an entire humidified incubator. With a culture period of21 
days, increasing the sample size, culture period, or number of experimental groups adds a 
significant amount of time to the length of any study. Multiplexing each system to allow 
for four valves was initially proposed, but eventually decided against to prevent cross-
influences of valves in the same culture medium. The production of a more compact 
system design that can share electronic components, such as the proportional pressure 
regulators, would be a promising direction for future development. Another option would 
be to remove the incubator size constraint by building or using an existing environmental 
chamber capable of maintaining its interior at 37° C and supplying humidified, 5% CO2 
air to the organ culture system's venting filter. 
A larger environmental chamber would also allow for a greater vertical distance between 
the atrial reservoir and ventricular chamber. The increased filling pressure may allow the 
system to achieve higher, more physiological, flow rates. As proposed in Chapter 4, other 
options to increase the filling pressure include simulating ventricular diastolic suction and 
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using an additional pneumatic pumping mechanism to simulate atrial systole, priming the 
ventricular chamber before its systolic phase. Another potential method to increase the 
flow rate would be to optimize the shapes and sizes of all the flow loop components. 
Similar flow loop bioreactors have been designed to minimize turbulence (97). Such a 
modification would likely enhance flow response. Recreating a more physiologic flow 
rate may improve retention of native valve characteristics, increasing the relevance of this 
organ culture model. 
The premise of this organ culture system relies on the accurate reproduction of the stress 
and strain distributions experienced by a mitral valve in vivo. In Chapter 4, modifications 
to the attachment of the chordae tendineae were proposed that are intended to better 
simulate their anatomic position. Because significant loads are applied through the 
chordae, their accurate positioning is important in modulating applied stresses and likely 
acts through mechanotransduction to influence valvular function and characteristics (48). 
It must also be considered that dynamic stimulation may not be the only factor required 
for an ideal mitral valve organ culture model. As demonstrated in Chapter 5, circulating 
molecules can significantly affect valvular characteristics. The addition of growth factors 
or other signaling agents has been beneficial to the development of tissue engineered 
heart valve constructs in combination with mechanical conditioning (35) and is likely to 
have similar effects in organ culture. Effects may even be seen with the substitution of 
bovine growth serum for fetal bovine serum, which is richer in a variety of proteins. 
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Wide Scope of Possible Future Research 
In addition to addressing these noted limitations, further use and development of the 
organ culture system offers a wide scope of possible investigation. The most 
straightforward and obvious options would be the addition of other common circulating 
molecules. Determining the effects of Vasopressin, Endothelin-l, Norepinephrine, and 
other agents related to heart failure could expand on the results from Aim 3 to better 
understand mitral valve remodeling and dysfunction in heart failure. 
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Without requiring any modifications, the flexibility of the system to produce a wide range 
of pressure signals allows simulation of hypertension and hypotension. Sub-physiologic . 
pressure waveforms could be used towards a mitral valve tissue engineering model. It 
may also be desirable to explore the valvular response to non-physiological pulsatile 
pressure waveforms, such as those created by pulsatile ventricular assist devices. These 
variations could also extend the research of heart valves in heart failure by simulating 
common modes of altered cardiac hemodynamics. 
The modular assembly of this system also increases its flexibility. For example, organ 
culture oftri-Ieaflet valves is achievable by simply modifying only the inlet port to 
accommodate these valves and reversing the direction of the mechanical valve. Such a 
system would not be novel, several similar configurations already exist (37, 42, 97, 98) . 
Culture ofa tricuspid valve (from the right side of the heart) should also be possible with 
minor modifications to the valve attachment scheme. 
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Conclusion 
An understanding of the factors that lead to valve disease, as well as those that maintain 
healthy valves, are both necessary components in the development of reliable and 
effective valve disease treatments and prevention. This thesis described the design and 
development of a mitral valve organ culture system and proceeded to document its 
capability as a resource for scientific exploration. Given the results and insights provided 
by all three chapters, I am pleased that the organ culture system will continue to develop 
and serve as a novel experimental tool in the field of heart valve biology. 
Appendix A DESIGN PROCESS 
The design criteria and resulting design have already been described in Chapter 3; this 
appendix is intended to document the design process connecting the two. 
Functions, Objectives, Constraints 
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In Chapter 3 the design criteria for the mitral valve organ culture system were categorized 
into the following functions, objectives, and constraints: 
Functions 
• Recreate the in vivo heart valve mechanical environment 
• Recreate the physiological valve geometry 
• Provide necessary nutrition and gas exchange for cellular metabolism 
• Maintain a sterile culture environment at 37° C and 5% C02 
Objectives 
• Maximize the viability of cells in cultured valves 
• Minimize the changes in tissue structure and composition 
• Minimize differences in flow characteristics 
• Minimize complexity of operation 
• Maximize flexibility of culture conditions 
• Maximize accurate control of culture conditions 
• Maximize consistency and repeatability of culture conditions 
• Maximize the number of valves in culture concurrently 
103 
Constraints 
• Avoid microbial contamination 
• Avoid leaks 
• Fit within an environmental incubator 
These design criteria provided bases for decisions on various design elements. 
Major Design Elements 
Pumping mechanism 
The following options were considered to produce pulsatile pressure and flow through the 
system: peristaltic pumping, bladder pumping, and piston pumping. 
Peristaltic pumping involves wrapping tubing around a rotor that compresses the tubing 
and presses fluid forward as it turns. There are many pump units commercially available 
that are intended for biomedical applications. Also, because no external or moving parts 
contact the flow medium, sterility is not compromised. However, due to the pumping 
mechanism, the flow and pressure achieved cannot accurately recreate physiological 
waveforms and it is difficult to uncouple flow rate and pulse frequency. It would also be 
difficult to simulate both diastolic and systolic conditions. In addition, these pumps can 
be large and would be difficult to implement within an incubator. 
Bladder pumping uses an inflatable bladder or diaphragm to propel fluid out of the 
pumping chamber, then allows the bladder to deflate as fluid refills the chamber. This 
pumping action is similar to the cyclic contractions of the heart. Bladder pumps can be 
created to accurately recreate a wide variety of pressure pulses. The bladder also acts as a 
barrier between the flow medium and any non-sterile pumping mechanisms A 
disadvantage is that the pumping system would have to be custom built. 
Piston pumping is nearly identical to bladder pumping, replacing the inflating bladder 
with a piston that displaces fluid at a variable rate as it moves. A piston can be accurately 
controlled, leading to accurate control of flow rates. A moving piston, however, would 
involve increased risk of leaks and contamination at the interface of the piston and its 
casing. The size of a piston system would also be of concern. 
Based on these options, a custom-built bladder pump was chosen as the pumping 
mechanism. The deciding factors were the flexibility of this mechanism, it's similarity to 
ventricular pumping, and the lack of sterility concerns. Bladder pumping also allowed for 
a pressure-controlled system, instead of one controlled through a direct volume 
displacement. Control through direct application of pressure was favored because 
pressure impulses were expected to better simulate the conditions of both diastole and 
systole. Several other cardiovascular bioreactor systems have used this approach (42, 44, 
98,99). 
Variable Pressure Supply 
In order to accurately control the pressure ofthe inflating bladder (diaphragm), a 
proportional pressure regulator (PPR) supplied compressed air at electrically controlled 
variable pressures. The initial PPR selected was a QB3 (ProportionAir, McCordsville, 
IN). This model had a large pressure range (0-7700 mmHg) and large air flow rate 
capacity. However, preliminary tests indicated the instrument was not well suited for the 
lower end of the pressure range, as the produced pressure waveforms were not smooth 
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and had a significant time lag from their control signal. The QB3 was substituted with an 
Airfit Tecno (Parker-Origa, Richland, MI), which had a more limited pressure range (0-
150 mmHg) and maximum flow rate capability, but also a much quicker and more 
precise pressure response. 
Ventricular Chamber 
First Iteration 
The first iteration of the ventricular chamber assembly is shown in Figure 6.1. The 
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ventricular chamber was made of custom machined acrylic parts. Acrylic was chosen for 
its clarity, to enable monitoring of the interior, and heat tolerance, to allow steam 
sterilization in an autoclave. Each half of the chamber was made of three parts held 
together with cyanoacrylate. A square 0.05" silicone membrane was clamped between the 
two chamber halves, which were pressed against each other with 12 tightened bolts. 
Silicone was chosen because of its heat tolerance and appropriate elasticity and 
toughness. In order to allow the membrane to remain slack while moving back and forth 
to displace fluid, the membrane was deformed into a cup shape and folded over itself in 
the clamping area. Two openings were bored into the fluid-filled chamber haIrs face to 
accommodate the valve holders. A threaded hole was also included to accommodate an 
electronic pressure sensor. 
The first mitral valve holder was (Figure 6.lc) also made with acrylic and had two halves 
clamped together with bolts with a silicone membrane in between. The silicone 
membrane was a swatch with a mechanical or porcin heart valve sutured to an orifice at 
its center. The mitral valve holder narrowed down and was fitted with a barbed tubing 
Figure 6.1. First iteration of A) Complete ventricular chamber assembly, B) Ventricular 
chamber only, and C) Mitral valve holder. 
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port on the inflow end. The outflow end was friction-fit into the corresponding opening in 
the ventricular chamber, using a teflon-tape wrap to secure the fit. The aortic valve holder 
(not shown) was a small acrylic shunt with a mechanical heart valve held in place by an 
acrylic ring stuck to the valve holer interior with silicone adhesive. It also was friction-fit 
into the corresponding ventricular chamber opening. 
Initial testing showed this design to contain several major flaws. Leaks were evident at 
nearly all types of interfaces between components: acrylic held together with 
cyanoacrylate, friction-fits between parts, the valve holder tubing port, and bolt-tightened 
acrylic clamped around silicone. The folded silicone membrane failed to move freely 
when pressure was applied to the air-filled side of the chamber. Also, tightening all of the 
bolts was difficult and time-consuming, and risked cracking the underlying acrylic parts. 
Revisions 
Through several iterations, the ventricular chamber assembly was revised to correct for 
all of the stated flaws (Figure 3.2). All uses of adhesives and bolts were discontinued and 
largely replaced with the use of o-rings. The inflexible flat silicone membrane was 
replaced with a thinner, dome-shaped, silicone diaphragm. It was still clamped between 
two halves of the ventricular chamber, but the clamping force was provided by an 
external frame held together with toggle clamps. The pressure sensor was moved from 
the fluid side of the chamber to the air side; tests with sensors simultaneously on both 
sides of the chamber confirmed the equivalence of the two measurement locations. 
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The mitral valve holder was modified towards a design more similar to the aortic valve 
holder. The current design consists of a single primary piece instead of two that are held 
together. The valve is sutured to a fabric swatch, which resists tearing much better than 
silicone and is also autoclaveable. The swatch is clamped in place with an interior "clamp 
ring" that is held into place by friction between the components, acting through a silicone 
o-nng. 
Chordal Anchoring 
The first attempt at chordal anchoring involved the simple insertion of curved steel wires 
through the excised papillary muscles. The wire ends were then passed through holes in 
the mitral valve holder wall to hold them in place (Figure 6.2). 
This scheme did not work at all. The wires would easily deflect towards the valve 
annulus immediately. In additon, the wires would tear through the papillary muscles 
during tests that lasted on the order of an hour. 
In order to avoid tearing, wire helices were formed that could wrap around the papillary 
muscles, and between chordae tendineae, without piercing any tissue. Stiffer straight 
wires were inserted through these helices into the valve holder wall. Additionally, 
multiple holes were bored in the mitral valve holder wall to allow chordae of varying 
lengths to be accomodated. 
Figure 6.2. Early implemenation of chordal anchoring. The steel wires were inserted 
through the papillary muscles and into the wall of the mitral valve holder. 
The rest of the system has undergone further, but minor development. The following 
appendix contains a detailed operating guide with some further details. 
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Appendix B FLOW Loop OPERATING MANUAL 
(January, 2011) 
Preparatory Steps 
Two days prior to harvest and start of culture: 
Prepare solutions: 
• Medium (MI99 wi Hank's Salts, L-glut, etc.) wi 10% BGS and 2% anti-microbial 
solution (> I.5L per valve is recommended) 
• Sterile PBS wi 10% anti-microbial solution (50mL per valve) 
All parts autoclaved in autoclave bags: 
Large bag (1 per valve): 
• VC rings and caps 
• Silicone diaphragm 
• aortic port (with valve and clamp ring) 
Large bag (I per valve): 
• all tubing 
• hose clamps 
• port plugs 
Large bag (1 per valve): 
• IxlL bottle and IxO.5L bottle (with bulkhead ports) 
• 1 normal bottle closure and 1 septum closure 
• Venting filter 
Large bag: 
• 1 + aluminum foil sheet (-13 "x 17") per valve to be dissected 
Medium bag (I per valve): 
• Mitral valve holder, including clamp ring 
• 4 straight steel wires 
Small bag (1 per valve): 
• several annulus attachment rings of various sizes/shapes 
• 4 steel wire chordal helices per valve 
Ensure that up-to-date control software (Flow Loop Controller) is installed on the control 
computer, along with the necessary LabView DAQmx and LabView Runtime Engine 
software. 
One day prior to harvest and start of culture: 
Pre-assembly of flow loop, partial assembly of ventricular chamber 
In a hood, assemble the bottles/tubing of the flow loop. Use care when handling the 
tubing ends, as these surfaces will eventually contact culture medium. Tighten hose 
clamps around all the tubing ports, especially the port from the atrial reservoir that 
connects to the mitral port (this tubing is larger and does not fit unless well-tightened). 
Make sure the septum closure is used for the compliance chamber. Plug the tubing ends 
with silicone port plugs (tiny translucent top-hats). The tubing ends can be protected by 
stuffing them into a sterilization pouch. 
In addition, assemble the air-side and medium-side of the ventricular chamber, including 
the frame. The entire assembly can be clamped together to keep interior surfaces 
protected and to ease handling. Place into a sterilization pouch for safety. Keep both 
items as well as funnels, and mitral ports in the hood so that they may be protected from 
contamination by the UV light. 
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Autociaving surgical tools, dissection tray 
Autoclave these and place them into a separate hood. If it is not in an autoclave bag, 
move the dissection tray straight from the autoclave to the hood to limit time for 
contamination. If it is in a bag, remove the bag carefully as it may get contaminated or 
have charred particles clinging to it. Also place scalpel blades and sutures in the hood. 
All such items, including the sterilization pouches, can be sprayed with EtOH to reduce 
the risk of bringing a contaminated surface into the hood. Leaving the items in the sterile 
biosafety cabinet where they will be exposed to the UV light overnight will further 
reduce this risk. 
Pre-Dissection 
Wear normal lab gloves for these steps (spray with 70% EtOH). 
Place sterile PBS/anti in water bath until it comes to room temp (37°C is not necessary 
since it will cool down anyways), then wipe down with 70% EtOH and place in the 
dissection hood. 
Place 2 50mL tubes per valve to be dissected into the dissection hood, label them 1, 1, 2, 
2 ... 
Make sure all dissection tools are available in the dissection hood. 
Prepare a sterile 250mL beaker mostly filled with 70% EtOH for cleaning dissection 
tools. Tools should be placed in this beaker when not used for extended periods; allow 
them to dry completely before contacting the mitral valve. 
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Prepare a clean 1-5L beaker/tub for the bio-waste, spray/wipe it with 70% EtOH and 
place it in the dissection hood. 
Heart Dissection 
Spread one sterile sheet of aluminum foil on the dissection tray surface. A double layer 
may help keep the tray surface clean. 
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Grab a fresh heart and place it on the foil sheet in the dissection hood. To prevent blood 
dripping, you can saturate a paper towel with 70% EtOH, hold the heart with the paper as 
you carry it, and then dispose of the paper into the bio-waste container. Also dispose of 
your (now bloody) gloves into the bio-waste. 
Open and wear a new pair of sterile gloves - these should already be in the hood. Also 
open up two sets of forceps and two scalpel holders; place blades on the scalpel holders. 
Identify and remove the main portion of the left atrium, as well as any other tissue 
obscuring the mitral valve. Use one set of forceps and one scalpel to work on exterior 
parts of the heart. Reserve the other forceps and scalpel for contact with the mitral valve. 
You can also remove coagulated blood from the vicinity of the mitral valve. Dispose of 
removed tissue and blood into the bio-waste container. 
Select an annulus attachment ring that best matches the dimensions of the valve annulus. 
You may want to use the valve sizing kit for this - try not to contaminate the attachment 
ring with anything that has touched the heart. 
Next, use the reserved scalpel to cut the valve annulus away from the atrioventricular 
vall. Leave a margin of myocardial tissue attached and be very careful not to cut through 
the valve itself. 
When the annulus is detached, use the exterior scalpel to slice open the left ventricle 
down to the apex. To avoid damaging the chordae or papillary muscles, this slice should 
be on the opposite side of the ventricle from the aorta. You should also visually inspect 
the heart interior as you cut to make sure you are not causing any damage to these valve 
parts. 
Remove any chordae or similar structures that connect the valve to a non-papillary 
muscle area of the ventricle. Then cut the papillary muscles away from the ventricular 
wall. Leave plenty of excess tissue, as this can be trimmed later. Use the interior scalpel 
and the reserved forceps to manipulate the mitral valve and papillary muscles. 
When the valve is completely detached, place it into one of the tubes marked' l' and 
submerge it with sterile PBS/anti solution. Agitate lightly to remove air pockets and to 
loosen coagulated blood. 
Remove the foil sheet and place it in the bio-waste and replace it with a clean one. 
Repeat the dissection for each heart. If sufficient quantities are available, you may want 
to use a new set of forceps and a new scalpel blade for each heart's interior to reduce 
possible cross-contamination. 
Suturing 
Before suturing your last valve, place your medium into a water bath to warm it up. 
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Put on a new pair of sterile gloves. A fresh pair of gloves may not be necessary for 
suturing each valve. 
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Take the valve out of the tube marked' l' and place it on the dissection tray. With a clean 
scalpel blade and unused forceps remove excessive tissue from the valve annulus, 
preserving a margin of connective and myocardial tissue. 
Find the selected annulus attachment ring and open up a sterile suture pack; place both on 
the dissection tray. 
Find the midpoint of the anterior leaflet segment on the attachment ring (Point A). Insert 
the suture needle just to the right of this point (about lmm), and 2-3 mm from the edge. 
Continue the needle into the anterior leaflet annulus, again about Imm to the right of the 
midpoint. The suture should cross through the 'stretchy/glossy' looking layer of the valve 
to ensure it does not pull through the tissue. The surfaces with rougher texture are 
generally created from cutting and do not support sutures as well. The suturing process is 
much easier if you directly hold the valve in your fingers, so be especially careful to 
keep your gloves sterile, generally by not touching anything outside the hood. Pull the 
suture through the valve and attachment ring on the other side of the midpoint. As you 
pull the suture through, it should bring the valve up to the attachment ring. Tie a 2xl 
instrument tie to knot the suture and trim the ends of the knot with the scalpel or 
dissection scissors. The knot should always be next to the attachment ring, not the tissue. 
Continue suturing at points B, C, etc ... The valve annulus at the posterior leaflet and 
commissures will seem too long to fit directly against the attachment ring. To attach these 
portions correctly they will have to form ridges/folds. Lining up the annulus with the ring 
can be tricky to keep a consistent folding density. Use the geometry of the valve for cues 
(ie where the commissures are), and also estimate Y2 or 113 the distance between existing 
suture points. You can then fill in the remaining points in an iterative process. The 
anterior leaflet can be secured with two to four 'long' suture knots. By the end of this 
process, the valve annulus should be held tightly to the attachment ring at all points -
forceps should not be able to open a gap. This may take a long time - valves often need 
24 knots, so you may occasionally submerge the valve into its first rinsing tube to keep it 
hydrated. 
Next trim away excess papillary muscle tissue so that the helical coils are able to fit 
around them. Each papillary muscle may also be split to separate the anterior leaflet 
chordae from the posterior leaflet chordae. This often leaves each portion of the papillary 
muscle with a single line of chordal attachments. Some papillary muscles will need to be 
sutured together if damaged in dissection or if they are not in one contiguous piece. 
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Twist the helical coils around the papillary muscles, interspersing the chordae through the 
helical gaps. If the number or spacing of the chordae leaves the papillary muscle able to 
slip, tie sutures through the muscle and around the coil wire. 
When finished place the valve, with ring and coils, into the unused tube labeled' 1 '. 
Again, submerge with PBS/anti- solution and agitate lightly. 
Repeat for each valve 
Assembly 
Take your prepared valves into the assembly hood (if this is different from the dissection 
hood). 
Open up the mitral valve holder sterilization pouch. With sterile forceps place the valve 
into it's appropriate position in the valve holder. Put the 'clamp ring' over the valve and 
press it down over the attachment ring. During this process, you will have to manipulate 
the coils to move them out of the way. Just before pressing the ring all the way against 
the opposing surface, make sure that the valve annulus is aligned correctly with the 
holder so that the placement wires will be able to slide through the coils in the proper 
orientation. 
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Use the placement wires to hold the coils extended from the annulus. Use the 2-3 rows of 
lsots in the mitral valve holder to keep the chordae elongated, but not taut or twisted. 
Next, fit the mitral valve holder into the ventricular chamber assembly. Because of the 
wires, the mitral valve holder will have to be inserted from the inside-out. Try not to bend 
the wires while inserting the holder - this may make them harder to remove. 
Line up the two sides of the ventricular chamber, with the membrane in between the two. 
Make sure that they are well aligned to prevent leaks. Flip the four buckles to hold the 
assembly in place. To test the tightness of the membrane, pull on its exposed edges, they 
should stretch and return to place. If they slip, either the two chamber sides are 
misaligned or the external frame must be adjusted. The ventricular chamber should now 
be completely assembled. 
Complete the assembly by connecting the pre-assembled loop tubing. Try to twist the 
tubing onto the mitral and aortic ports so that, in the system's final configuration in the 
incubator, the tubing does not exert a twisting force on the ventricular chamber. This will 
take some practice. 
Filling 
Unscrew the closure of the atrial reservoir and place it on a clean surface in the hood, 
such as the inner surface of an autoclave pouch. Put a sterile funnel into the top of the 
atrial reservoir. 
Pour medium into the system. Once the medium is at the level of the venting filter, lift 
the atrial reservoir above either the ventricular chamber or compliance chamber to 
distribute the medium. The ventricular chamber should be arranged with the aortic port 
high and the mitral port low. This ensures that medium can flow in through the mitral 
port and that air can be pushed up and out through the aortic port. Get the compliance 
chamber to fill quickly initially by loosening its cap - close the cap when the medium 
reached the cap level. Continue to fill the system through the atrial reservoir 
progressively. 
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When filled fully the compliance chamber will be about half full and all the tubing should 
be filled with medium. Lift the two bottles above the ventricular chamber; the ventricular 
chamber should be full of medium - shake out large air pockets; the atrial reservoir 
should have medium just above the level of the two ports. The smaller systems will take 
roughly 1.3L of medium to fill. The biggest system (the original one) takes around 1.7L. 
Once filled, make sure all caps are tightened and that there are no signs of medium 
leaking from the tubing ports. 
Repeat for each valve/system. 
Pipette -6mL of the unused medium into a 10mL c-tube for pH testing. Label it "(sample 
name) Od medium (initial-date)." This needs to be done only once per medium 
formulation used (not once per valve). 
This is also a good opportunity to label the system(s) with lab tape so that they don't get 
mixed up on their way to, or while in, the incubator. 
Putting the System in the Incubator, Connecting Cables, and Starting it 
up 
Move the system into the incubator. The top rack will have to be pulled out most of the 
way. Move the whole system into the incubator between the top and bottom rack, with 
the bottles going in fIrst. Pass them behind and onto the top rack, making sure not to 
invert them such that medium flows into the venting filter. Straighten out the bottles on 
the top rack and move the top rack back into position. Remove any twists or extraneous 
bends in the tubing and arrange the ventricular chamber so that the medium-fIlled side 
faces the incubator interior and the aortic port is above the mitral port. 
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Noting which set of connections are for Flow System A, screw the pressure transducer 
and the tube from the pressure regulator into the base of the ventricular chamber. When 
appropriate, clamp the flow meter onto tubing just upstream of the mitral port - make sure 
the 'Flow' arrow points towards the ventricular chamber. Also check that the flow meter 
is plugged into the correct plug on the control box (System A or B). The system is now 
ready to be started. 
If it is not yet running, start the Flow Loop Controller software. Adjust the pressure to the 
desired peak (normally 120 mmHg) and make sure that the waveform selected is correct 
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(normally "Physiological Signal"). Check all the other settings. Click 'Start' and name the 
recording file. After a few seconds the system should begin pumping. Click 'Record 
Single Sample' to get a baseline recording. The flow profile should show a short spike of 
regurgitant flow at the onset of systole, followed by near-zero flow and then forward flow 
through the mitral valve during diastole. Bubbles in the tubing near the flow probe may 
cause a lot of noise, but they will dissipate within an hour or so. Move the flow probe 
(and the flow meter cable to the control box) to the other system and record a baseline 
cycle. 
Check the pH of the saved medium in the c-tube and record it. 
Operation 
Every day move the flow probe from one system to the other. First unplug the connection 
at the control box, then switch the probe, and lastly plug the connection into the other 
socket on the control box. Low flow levels or abnormal waveforms can indicate problems 
within the system. Also monitor the fluid levels in all components of the flow loop and 
check for signs of contamination. Medium samples can be obtained while maintaining 
sterile conditions by inserting a sterile syringe (w/ needle!) in through the septum closure 
of the compliance chamber. 
Medium Exchange 
After 7 days, each system's culture medium must be replaced. Prepare by autoclaving a 
funnel and warming new medium in the water bath. If you'd like you can also warm some 
PBS/anti-microbial solution to rinse the system. Put a clean 4-SL griffin beaker in the 
hood to collect used medium. It is also useful to have some sterile forceps available. 
Pause the first system to be processed (the corresponding waveforms should flatten out) 
and disconnect the pressure transducer and pressure regulator and switch the flow probe 
if necessary. 
Draining the System 
Move the entire flow loop into a sterile hood. Prepare a 10mL c-tube and a T75 flask, 
label them as "(sample name) 7d (or l4d) medium (initials & date)." Remove the closure 
from the atrial reservoir. Pipette about 6 mL of used medium into the c-tube and 6 mL 
into the flask. The c-tube medium's pH will be checked, recorded and compared with the 
Od sample. The flask will be placed in the incubator and checked under a microscope 
after 1-2 days for bacterial contamination. 
Put the atrial reservoir closure back and remove the compliance chamber closure (but 
don't spill!). Now just lift the whole system and pour the medium out into the griffin 
beaker. You'll probably have to shake the ventricular chamber a bit to get the medium 
out, and there will still be a small amount remaining. At this point you may add -20mL 
of the PBS/anti-microbial solution and slosh it through the system. Drain it out (or don't, 
it doesn't make a big difference). 
While the system is empty, visually inspect the aortic and mitral ports to see if everything 
is still in place. You can also replace the venting filter with a sterile one if medium has 
leaked into the filter. 
Refilling and Restarting 
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Pour new medium into the system, as described earlier, and place it into the incubator. 
Re-attach the pressure transducer and regulator. Resume the system's operation and move 
the flow probe back to check the flow/pressure waveforms. 
Repeat for each system. 
Stopping and Disassembly 
Prepare a c-tube and T75 flask for medium collection for each system, as described above 
for medium exchange -label them as 2Id (or whatever time point it is). Also prepare a 
50mL c-tube and label with the sample names. 
Stopping the system: 
Just press 'Stop' on the program. Easy! 
Disassembly 
Next, disconnect the pressure regulator, pressure transducer, and flow meter from the 
systems. 
Do the draining part ofthe medium exchange procedure. Now you should have an empty 
system in the hood. Remove the tubing from and unlatch the ventricular chamber. Push 
the mitral port out of place through the interior of the ventricular chamber. This is 
necessary since there are still wires holding the chordae in place. Also, try not to twist the 
port too much; the wires will scratch the ventricular chamber interior. During these steps 
some medium will spill out and that's okay, just make sure to clean it up. 
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Next, remove the straight wires to release the papillary muscle helices. Now you can 
remove the mitral valve: Push on the fabric attachment ring with your gloved finger to 
get it out from its position. You can also use fingers/forceps/hemastats/pliers to pull the 
clamp ring a little out of position to loosen the attachment ring. Twist off the wire helices 
and place the valve into the appropriately labeled 50mL c-tube. 
Submerge the valves with PBS (non-sterile is fine). 
Move the system, including all parts, out of the hood. Disassemble all parts and rinse 
with DI water. The compliance chamber often has a bit of medium residue in a few 
places. There's still no good procedure for minimizing and cleaning offthe residue, so 
replace the chamber when you think there's too much. 
Valve Dissection 
You will dissect the valve and retain seven portions for various assays (Or you may 
decide on a different scheme better suited to your study): 
• Anterior Circumferential strip (AC) - for tensile testing and histology 
• Anterior Radial strip (AR) - for tensile testing and histology 
• Anterior Strut Chordae (ChI & Ch2) - for tensile testing and histology 
• Anterior leaflet (A) - for biochemical assays 
• Posterior Radial strip (PR) - for tensile testing and histology 
• Posterior leaflet (P) - for biochemcal assays 
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Prepare seven labeled micro-c-tubes for each valve (labeled: "sample" "portion", eg AL3 
PR). 
Start by removing the sutures - cut them at the knot with a scalpel or razor blade and pull 
them out with forceps. Once done, make a radial cut through the middle of the lateral 
commissure. Lay the valve on the dissection tray, ventricular side up; this may also 
require splitting a papillary muscle. Take a photo of the valve, including the cap ofthe c-
tube or something else labeled with the sample name. You may also want to record any 
observations, such as those on the appearance of the valve. 
Start dissection by using a razor blade to cut out a -3-5 mm wide rectangular 
circumferential strip from the 'anterior center' - the bottom of the strip should be just 
above the first set of chordae and the top should be as close to the annulus as you can get 
without getting the thicker connective tissue beyond the ends of the section. Take as long 
a strip as possible while not including any commissure tissue. Place this strip in the AC 
micro-c-tube along with a squirt of PBS. Use a razor blade again to cut the AR portion 
from between the two central rows of chordae extending from the leaflet - this strip 
should be as wide as possible without touching the chordae. Again, place it in the AR 
micro-c-tube with a squire of PBS. Detach the rest of the anterior leaflet from the 
commissures and remove any annular tissue (anything above the bottom cut of the AC 
strip). Use pins to hold the remaining leaflet tissue down while removing the chordae 
with forceps and a scalpel blade. The two largest strut chordae should be at the top and 
must removed completely intact and placed in micro-c-tubes (with minimal papillary 
muscle). Place the remaining, chordae-less, anterior leaflet tissue into the "A" micro-c-
tube. 
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Now move to the posterior leaflet. Detach the leaflet from the adjoining commissures. 
Obtain the PR section by cutting just as the AR sect jon was cut, but all the way to the 
annulus. Remove all the chordae, do not worry about saving any for testing, and place the 
chordae-less leaflet sections into the "P" micro-c-tube. Discard any remaining tissue. 
Freeze the A and P sections for biochemical assays. 
Perform tensile testing on each of the remaining portions (see procedure) and then place 
them into labelled histology cassettes. Store them in 10% formalin overnight and begin 
flex/xylene dehydration the next day. 
Clean-Up 
Just make sure all the stuff you used is washed and, once dry, put back. Also wipe down 
the hood(s) and incubator. 
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